Mototsugu Oya
#155,913
Most Influential Person Now
Researcher
Mototsugu Oya's AcademicInfluence.com Rankings
Mototsugu Oyacomputer-science Degrees
Computer Science
#8571
World Rank
#9010
Historical Rank
Computational Linguistics
#1934
World Rank
#1955
Historical Rank
Machine Learning
#3545
World Rank
#3589
Historical Rank
Artificial Intelligence
#3854
World Rank
#3910
Historical Rank
Download Badge
Computer Science
Mototsugu Oya's Degrees
- PhD Computer Science University of Tokyo
- Masters Computer Science University of Tokyo
- Bachelors Computer Science University of Tokyo
Similar Degrees You Can Earn
Why Is Mototsugu Oya Influential?
(Suggest an Edit or Addition)Mototsugu Oya's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Renal angiomyolipoma: a radiological classification and update on recent developments in diagnosis and management (2014) (243)
- Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. (2009) (207)
- Adrenocortical zonation in humans under normal and pathological conditions. (2010) (207)
- Preliminary results for avelumab plus axitinib as first-line therapy in patients with advanced clear-cell renal-cell carcinoma (JAVELIN Renal 100): an open-label, dose-finding and dose-expansion, phase 1b trial. (2018) (201)
- Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases. (2009) (178)
- Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer. (2004) (174)
- Activation of signal transducer and activator of transcription 3 in renal cell carcinoma: a study of incidence and its association with pathological features and clinical outcome. (2002) (173)
- Constitutive activation of nuclear factor-κB prevents TRAIL-induced apoptosis in renal cancer cells (2001) (164)
- Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. (2010) (155)
- Preoperative nomograms for predicting stone-free rate after extracorporeal shock wave lithotripsy. (2006) (138)
- Renal cancer cells lacking hypoxia inducible factor (HIF)-1α expression maintain vascular endothelial growth factor expression through HIF-2α (2006) (135)
- Whole-tissue biopsy phenotyping of three-dimensional tumours reveals patterns of cancer heterogeneity (2017) (124)
- Increased nuclear factor-kappa B activation is related to the tumor development of renal cell carcinoma. (2003) (123)
- Suppression of hormone-refractory prostate cancer by a novel nuclear factor kappaB inhibitor in nude mice. (2003) (122)
- Renal cell carcinoma: etiology, incidence and epidemiology (2004) (117)
- Interleukin 6 is associated with cachexia in patients with prostate cancer. (2007) (116)
- Preoperative hydronephrosis grade independently predicts worse pathological outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma. (2011) (105)
- Expression of Snail and Slug in renal cell carcinoma: E-cadherin repressor Snail is associated with cancer invasion and prognosis (2011) (105)
- Renal cancer cells lacking hypoxia inducible factor (HIF)-1alpha expression maintain vascular endothelial growth factor expression through HIF-2alpha. (2007) (102)
- Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration. (2009) (102)
- Akt activation in renal cell carcinoma: contribution of a decreased PTEN expression and the induction of apoptosis by an Akt inhibitor. (2004) (98)
- Expression of TNF‐α and CD44 is implicated in poor prognosis, cancer cell invasion, metastasis and resistance to the sunitinib treatment in clear cell renal cell carcinomas (2015) (95)
- Elevated Akt activation and its impact on clinicopathological features of renal cell carcinoma. (2003) (94)
- STAT3, but not ERKs, mediates the IL-6-induced proliferation of renal cancer cells, ACHN and 769P. (2002) (93)
- Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas (2009) (92)
- Activation of the aryl hydrocarbon receptor pathway enhances cancer cell invasion by upregulating the MMP expression and is associated with poor prognosis in upper urinary tract urothelial cancer. (2010) (92)
- Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma (2009) (91)
- Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study. (2009) (82)
- Nicotine Induces Tumor Growth and Chemoresistance through Activation of the PI3K/Akt/mTOR Pathway in Bladder Cancer (2015) (76)
- Axitinib dose titration: analyses of exposure, blood pressure and clinical response from a randomized phase II study in metastatic renal cell carcinoma. (2015) (72)
- Lysophosphatidic acid activates Arf6 to promote the mesenchymal malignancy of renal cancer (2016) (72)
- The predictive value of C-reactive protein for prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: a multi-institutional study. (2014) (71)
- A Germ Cell-specific Gene, Prmt5, Works in Somatic Cell Reprogramming* (2011) (68)
- MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer (2020) (64)
- Assessment of long-term quality of life using the FACT-BL questionnaire in patients with an ileal conduit, continent reservoir, or orthotopic neobladder. (2006) (63)
- Technical difficulties of transumbilical laparoendoscopic single-site adrenalectomy: comparison with conventional laparoscopic adrenalectomy (2010) (63)
- Case Report: Nodule Development From Subcapsular Aldosterone-Producing Cell Clusters Causes Hyperaldosteronism. (2016) (62)
- Expression of Snail in Upper Urinary Tract Urothelial Carcinoma: Prognostic Significance and Implications for Tumor Invasion (2010) (61)
- Laparoscopic surgical correction ofcircuivicaval ureter (1994) (59)
- Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup analysis from the CheckMate 025 study (2017) (57)
- A Multi-Institutional Validation of the Prognostic Value of the Neutrophil-to-Lymphocyte Ratio for Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy (2014) (57)
- Angiotensin II type 1 receptor expression and microvessel density in human bladder cancer. (2011) (56)
- Gemcitabine and paclitaxel chemotherapy for advanced urothelial carcinoma in patients who have received prior cisplatin-based chemotherapy (2008) (55)
- Prognostic value of plasma fibrinogen levels in patients with localized upper tract urothelial carcinoma (2013) (53)
- Role of computed tomography urography in the clinical evaluation of upper tract urothelial carcinoma (2016) (53)
- Long-term androgen ablation and docetaxel up-regulate phosphorylated Akt in castration resistant prostate cancer. (2011) (51)
- Ets‐1 and hypoxia inducible factor‐1α inhibition by angiotensin II type‐1 receptor blockade in hormone‐refractory prostate cancer (2009) (51)
- Kidney Cancer Working Group report. (2010) (50)
- Intrarenal satellites of renal cell carcinoma: histopathologic manifestation and clinical implication. (1995) (49)
- The predictive value of positive urine cytology for outcomes following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma: a multi-institutional study. (2014) (49)
- Evidenced‐based clinical practice guideline for upper tract urothelial carcinoma (summary – Japanese Urological Association, 2014 edition) (2015) (48)
- Laparoscopic surgical correction of circumcaval ureter. (1994) (48)
- Increased activation of CCAAT/enhancer binding protein-beta correlates with the invasiveness of renal cell carcinoma. (2003) (48)
- Prediction of bone metastases by combination of tartrate‐resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with prostate cancer (2008) (47)
- Guidelines for treatment of renal injury during cancer chemotherapy 2016 (2017) (47)
- Visceral obesity is a strong predictor of perioperative outcome in patients undergoing laparoscopic radical nephrectomy (2012) (45)
- Vitamin E succinate induced apoptosis and enhanced chemosensitivity to paclitaxel in human bladder cancer cells in vitro and in vivo (2010) (44)
- Immunohistochemistry of aldosterone synthase leads the way to the pathogenesis of primary aldosteronism (2017) (43)
- Prediction of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer (2003) (43)
- Incidence and growth pattern of simple cysts of the kidney in patients with asymptomatic microscopic hematuria (2003) (43)
- Metastatic Behavior of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy: Association with Primary Tumor Location (2014) (42)
- Clinical outcome of tumor recurrence for Ta, T1 non‐muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999–2001 report from the Japanese Urological Association (2009) (42)
- Invasion and metastasis of renal cell carcinoma (2014) (42)
- First-line avelumab + axitinib therapy in patients (pts) with advanced renal cell carcinoma (aRCC): Results from a phase Ib trial. (2017) (41)
- The Prognostic Significance of Vasohibin-1 Expression in Patients with Upper Urinary Tract Urothelial Carcinoma (2012) (41)
- Chromophobe renal cell carcinoma, oncocytic variant: a proposal of a new variant giving a critical diagnostic pitfall in diagnosing renal oncocytic tumors (2013) (40)
- Human Adrenocortical Remodeling Leading to Aldosterone-Producing Cell Cluster Generation (2016) (39)
- High Absolute Monocyte Count Predicts Poor Clinical Outcome in Patients with Castration-Resistant Prostate Cancer Treated with Docetaxel Chemotherapy (2016) (38)
- Recent advances in renal cell carcinoma from a pathological point of view (2016) (38)
- Diagnosis of Renal Angiomyolipomas: Classic, Fat-Poor, and Epithelioid Types. (2017) (38)
- Recent trends in the initial therapy for newly diagnosed prostate cancer in Japan. (2014) (38)
- Epithelioid angiomyolipoma of the kidney: Radiological imaging (2013) (38)
- The prognostic significance of vasohibin-1 expression in patients with prostate cancer (2013) (37)
- Inhibition of MKP-1 expression potentiates JNK related apoptosis in renal cancer cells. (2004) (37)
- Overall Survival Analysis From a Randomized Phase II Study of Axitinib With or Without Dose Titration in First-Line Metastatic Renal Cell Carcinoma. (2016) (37)
- Dual PI3K/mTOR inhibitor NVP-BEZ235 sensitizes docetaxel in castration resistant prostate cancer. (2014) (36)
- Tumor budding, a novel prognostic indicator for predicting stage progression in T1 bladder cancers (2016) (36)
- Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup 3-year follow-up analysis from the Phase III CheckMate 025 study. (2019) (36)
- Extraperitoneal approach induces postoperative inguinal hernia compared with transperitoneal approach after laparoscopic radical prostatectomy. (2010) (36)
- Angiotensin II Type 1 Receptor Antagonist as an Angiogenic Inhibitor in Urogenital Cancer. (2009) (35)
- The pretreatment neutrophil-to-lymphocyte ratio is a novel biomarker for predicting clinical responses to pembrolizumab in platinum-resistant metastatic urothelial carcinoma patients. (2020) (35)
- Visceral obesity is associated with better recurrence-free survival after curative surgery for Japanese patients with localized clear cell renal cell carcinoma. (2015) (35)
- Impact of smoking status on bladder tumor recurrence after radical nephroureterectomy for upper tract urothelial carcinoma. (2013) (35)
- Abiraterone and Olaparib for Metastatic Castration-Resistant Prostate Cancer (2022) (35)
- Incidence of seed migration to the chest, abdomen, and pelvis after transperineal interstitial prostate brachytherapy with loose 125I seeds (2011) (34)
- C-jun activation in acquired cystic kidney disease and renal cell carcinoma. (2005) (34)
- Decreased acetylation of histone H3 in renal cell carcinoma: a potential target of histone deacetylase inhibitors. (2007) (34)
- Identification of drug candidate against prostate cancer from the aspect of somatic cell reprogramming (2013) (34)
- Prognostic significance of Bacillus Calmette‐Guérin failure classification in non‐muscle‐invasive bladder cancer (2012) (34)
- Prognostic Value of Renin–Angiotensin System Blockade in Non-muscle-invasive Bladder Cancer (2012) (33)
- Down-regulation of NF kappa B activation is an effective therapeutic modality in acquired platinum-resistant bladder cancer (2015) (33)
- Expression of Heparanase in Renal Cell Carcinomas: Implications for Tumor Invasion and Prognosis (2008) (33)
- Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification. (2009) (33)
- PROpel: Phase III trial of olaparib (ola) and abiraterone (abi) versus placebo (pbo) and abi as first-line (1L) therapy for patients (pts) with metastatic castration-resistant prostate cancer (mCRPC). (2022) (32)
- Expression of Ets‐1 in human clear cell renal cell carcinomas: Implications for angiogenesis (2006) (32)
- Discontinuance of bacille Calmette-Guérin instillation therapy for nonmuscle-invasive bladder cancer has negative effect on tumor recurrence. (2009) (32)
- Clinical significance of programmed death‐1 and programmed death‐ligand 1 expression in the tumor microenvironment of clear cell renal cell carcinoma (2019) (31)
- Neoadjuvant gemcitabine plus cisplatin for muscle-invasive bladder cancer. (2011) (31)
- The predictors of local recurrence after radical cystectomy in patients with invasive bladder cancer. (2008) (31)
- Acquired platinum resistance enhances tumour angiogenesis through angiotensin II type 1 receptor in bladder cancer (2011) (31)
- Safety of pazopanib and sunitinib in treatment-naive patients with metastatic renal cell carcinoma: Asian versus non-Asian subgroup analysis of the COMPARZ trial (2018) (31)
- Nivolumab plus ipilimumab versus sunitinib in previously untreated advanced renal-cell carcinoma: analysis of Japanese patients in CheckMate 214 with extended follow-up (2019) (31)
- Patient characteristics and outcomes in metastatic upper tract urothelial carcinoma after radical nephroureterectomy: the experience of Japanese multi‐institutions (2013) (31)
- Prognostic Role of KiSS-1 and Possibility of Therapeutic Modality of Metastin, the Final Peptide of the KiSS-1 Gene, in Urothelial Carcinoma (2012) (31)
- Regulation of monocyte chemoattractant protein-1 through angiotensin II type 1 receptor in prostate cancer. (2012) (30)
- Aldosterone and 18-Oxocortisol Coaccumulation in Aldosterone-Producing Lesions (2018) (30)
- MUC1-C Activates the BAF (mSWI/SNF) Complex in Prostate Cancer Stem Cells (2020) (30)
- Variant isoforms of CD44 involves acquisition of chemoresistance to cisplatin and has potential as a novel indicator for identifying a cisplatin-resistant population in urothelial cancer (2018) (29)
- Survivin associates with cell proliferation in renal cancer cells: Regulation of survivin expression by insulin-like growth factor-1, interferon-γ and a novel NF-κB inhibitor (2006) (29)
- Activation of aryl hydrocarbon receptor promotes invasion of clear cell renal cell carcinoma and is associated with poor prognosis and cigarette smoke (2015) (28)
- Expression of G1→S Transition Regulatory Molecules in Human Urothelial Cancer (1998) (28)
- Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic renal cell carcinoma treated with first-line and subsequent second-line targeted therapy: A proposal of the modified-IMDC risk model. (2017) (28)
- Predictive factors for severe and febrile neutropenia during docetaxel chemotherapy for castration-resistant prostate cancer (2015) (28)
- Optimal Ratio of Transcription Factors for Somatic Cell Reprogramming* (2012) (28)
- Enhancement of radiosensitivity by a unique novel NF-κB inhibitor, DHMEQ, in prostate cancer (2012) (28)
- Long term follow-up in patients with initially diagnosed low grade Ta non-muscle invasive bladder tumors: tumor recurrence and worsening progression (2014) (28)
- The clinical significance of urine cytology after a radical cystectomy for urothelial cancer (2010) (28)
- Prognonstic impact of renin-angiotensin system blockade in localised upper-tract urothelial carcinoma (2011) (27)
- The Conditional Survival with Time of Intravesical Recurrence of Upper Tract Urothelial Carcinoma (2017) (27)
- Occurrence of infection following prostate biopsy procedures in Japan: Japanese Research Group for Urinary Tract Infection (JRGU) - a multi-center retrospective study. (2014) (27)
- Angiomyolipoma with epithelial cysts of the kidney in a man (2008) (27)
- Refraining from Smoking for 15 Years or More Reduced the Risk of Tumor Recurrence in Non-muscle Invasive Bladder Cancer Patients (2016) (27)
- Contrast-enhanced ultrasonography of the prostate with Sonazoid. (2010) (27)
- Simple Stratification of Survival Using Bone Scan and Serum C-Reactive Protein in Prostate Cancer Patients with Metastases (2008) (26)
- Sulfasalazine could modulate the CD44v9‐xCT system and enhance cisplatin‐induced cytotoxic effects in metastatic bladder cancer (2019) (26)
- Late recurrence and progression in non-muscle-invasive bladder cancers after 5-year tumor-free periods. (2010) (26)
- Avelumab plus axitinib vs sunitinib for advanced renal cell carcinoma: Japanese subgroup analysis from JAVELIN Renal 101 (2019) (26)
- A large-scale prospective registration study of the safety and efficacy of sorafenib tosylate in unresectable or metastatic renal cell carcinoma in Japan: results of over 3200 consecutive cases in post-marketing all-patient surveillance (2015) (26)
- Transumbilical approach for laparo‐endoscopic single‐site adrenalectomy: Initial experience and short‐term outcome (2012) (26)
- Impact of an adjuvant chemotherapeutic regimen on the clinical outcome in high risk patients with upper tract urothelial carcinoma: a Japanese multi-institution experience. (2015) (26)
- C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy. (2013) (25)
- Somatic KCNJ5 mutation occurring early in adrenal development may cause a novel form of juvenile primary aldosteronism (2017) (25)
- Analysis of cabazitaxel‐resistant mechanism in human castration‐resistant prostate cancer (2018) (25)
- Prognostic significance of Bcl-xL expression and efficacy of Bcl-xL targeting therapy in urothelial carcinoma (2013) (25)
- MUC1-C activates the PBAF chromatin remodeling complex in integrating redox balance with progression of human prostate cancer stem cells (2021) (25)
- Angiotensin II type 1 receptor antagonist enhances cis-dichlorodiammineplatinum-induced cytotoxicity in mouse xenograft model of bladder cancer. (2009) (25)
- A prospective longitudinal survey of erectile dysfunction in patients with localized prostate cancer treated with permanent prostate brachytherapy. (2012) (25)
- Comparison of genitourinary and gastrointestinal toxicity among four radiotherapy modalities for prostate cancer: Conventional radiotherapy, intensity-modulated radiotherapy, and permanent iodine-125 implantation with or without external beam radiotherapy. (2015) (25)
- Single‐cell RNA‐seq analysis reveals the platinum resistance gene COX7B and the surrogate marker CD63 (2018) (24)
- Acquired platinum resistance involves epithelial to mesenchymal transition through ubiquitin ligase FBXO32 dysregulation. (2016) (24)
- Maximum tumor diameter is a simple and valuable index associated with the local extent of disease in clinically localized prostate cancer (2006) (24)
- Clinical Role of Programmed Cell Death-1 Expression in Patients with Non-muscle-invasive Bladder Cancer Recurring After Initial Bacillus Calmette–Guérin Therapy (2018) (23)
- Tumour length of the largest focus predicts prostate‐specific antigen‐based recurrence after radical prostatectomy in clinically localized prostate cancer (2009) (23)
- Prognostic Impact of Renin–Angiotensin System Blockade on Renal Cell Carcinoma After Surgery (2015) (23)
- Bisebromoamide, an extract from Lyngbya species, induces apoptosis through ERK and mTOR inhibitions in renal cancer cells (2013) (23)
- The prognostic significance of OCT4 expression in patients with prostate cancer. (2016) (23)
- Papillary renal cell carcinoma: clinicopathological characteristics in 40 patients (2008) (23)
- Surgical and Chemotherapeutic Options for Urachal Carcinoma: Report of Ten Cases and Literature Review (2011) (23)
- Cis-dichlorodiammineplatinum Upregulates Angiotensin II Type 1 Receptors through Reactive Oxygen Species Generation and Enhances VEGF Production in Bladder Cancer (2010) (22)
- Initial experience of transumbilical laparoendoscopic single-site surgery of partial adrenalectomy in patient with aldosterone-producing adenoma (2010) (22)
- Extrapancreatic solid pseudopapillary tumor: case report and review of the literature (2012) (22)
- How does visceral obesity affect surgical performance in laparoscopic radical nephrectomy? (2015) (22)
- Burden of overactive bladder symptom on quality of life in stroke patients (2013) (22)
- Prognostic Value of Pretreatment Albumin‐to‐Globulin Ratio in Patients With Non–Muscle‐Invasive Bladder Cancer (2018) (22)
- Visceral fat is correlated with prolonged operative time in laparoendoscopic single-site adrenalectomy and laparoscopic adrenalectomy. (2013) (22)
- Laparoendoscopic single-site adrenalectomy versus conventional laparoscopic adrenalectomy: a comparison of surgical outcomes and an analysis of a single surgeon’s learning curve (2014) (22)
- Plasma fibrinogen level: an independent prognostic factor for disease‐free survival and cancer‐specific survival in patients with localised renal cell carcinoma (2016) (22)
- Prognostic value of preoperative multiparametric magnetic resonance imaging (MRI) for predicting biochemical recurrence after radical prostatectomy (2014) (21)
- Patterns of interstitial lung disease during everolimus treatment in patients with metastatic renal cell carcinoma. (2012) (21)
- External Validation of the MSKCC and IMDC Risk Models in Patients Treated with Targeted Therapy as a First-line and Subsequent Second-line Treatment: A Japanese Multi-institutional Study. (2016) (21)
- Renal cell carcinoma: biological features and rationale for molecular-targeted therapy. (2009) (21)
- Reactive oxygen species induction by cabazitaxel through inhibiting Sestrin-3 in castration resistant prostate cancer (2017) (21)
- Preoperative hydronephrosis: independent predictor for changes in renal function following nephroureterectomy. (2012) (21)
- Bladder metastasis from renal cell carcinoma: retrospective analysis of 65 reported cases (2015) (21)
- Profiling the inhibitory receptors LAG-3, TIM-3, and TIGIT in renal cell carcinoma reveals malignancy (2020) (20)
- Unidirectional barbed suture for vesicourethral anastomosis during laparoscopic radical prostatectomy (2014) (20)
- The Preoperative Neutrophil-to-lymphocyte Ratio is a Novel Biomarker for Predicting Worse Clinical Outcomes in Non-muscle Invasive Bladder Cancer Patients with a Previous History of Smoking (2016) (20)
- Risk of subsequent tumour recurrence and stage progression in bacille Calmette‐Guérin relapsing non‐muscle‐invasive bladder cancer (2012) (20)
- The Novel NF-κB Activation Inhibitor Dehydroxymethyl-Epoxyquinomicin Suppresses Anti-Thy1.1-Induced Glomerulonephritis in Rats (2008) (20)
- Prognostic significance of grade 3/4 neutropenia in Japanese prostate cancer patients treated with cabazitaxel (2018) (20)
- Urinary pH is highly associated with tumor recurrence during intravesical mitomycin C therapy for nonmuscle invasive bladder tumor. (2011) (20)
- Tracing the Conversion Process from Primordial Germ Cells to Pluripotent Stem Cells in Mice1 (2012) (19)
- Relationship Between Increased Expression of the Axl/Gas6 Signal Cascade and Prognosis of Patients with Upper Tract Urothelial Carcinoma (2016) (19)
- Could patient age influence tumor recurrence rate in non-muscle-invasive bladder cancer patients treated with BCG immunotherapy? (2011) (19)
- The implications of prostate-specific antigen density to predict clinically significant prostate cancer in men ≤ 50 years. (2014) (19)
- Intravesical interleukin-15 gene therapy in an orthotopic bladder cancer model. (2011) (19)
- Independent Predictors for Bladder Outcomes after Treatment of Intravesical Recurrence following Radical Nephroureterectomy in Patients with Primary Upper Tract Urothelial Carcinoma (2014) (19)
- Variant isoforms of CD44 expression in upper tract urothelial cancer as a predictive marker for recurrence and mortality. (2016) (19)
- Combined androgen blockade achieved better oncological outcome in androgen deprivation therapy for prostate cancer: Analysis of community‐based multi‐institutional database across Japan using propensity score matching (2018) (19)
- Surgical outcome of laparoscopic surgery, including laparoendoscopic single-site surgery, for retroperitoneal paraganglioma compared with adrenal pheochromocytoma. (2014) (19)
- Prognostic Value of Baseline Serum C‐Reactive Protein Level in Intermediate‐Risk Group Patients With Metastatic Renal‐Cell Carcinoma Treated by First‐Line Vascular Endothelial Growth Factor–Targeted Therapy (2018) (19)
- Inhibition of the ubiquitin-proteasome pathway activates stress kinases and induces apoptosis in renal cancer cells. (2004) (19)
- Angiogenic, inflammatory and immunologic markers in predicting response to sunitinib in metastatic renal cell carcinoma (2017) (18)
- Impact of baseline visceral fat accumulation on prognosis in patients with metastatic renal cell carcinoma treated with systemic therapy (2017) (18)
- New genetic causes of pheochromocytoma: current concepts and the clinical relevance. (2005) (18)
- Prioritising Urological Surgery in the COVID-19 Era: A Global Reflection on Guidelines (2020) (18)
- Impact of novel techniques on minimally invasive adrenal surgery: trends and outcomes from a contemporary international large series in urology (2016) (18)
- Increased vasohibin-1 expression is associated with metastasis and poor prognosis of renal cell carcinoma patients. (2017) (17)
- Key predictive factors for efficacy of axitinib in first-line metastatic renal cell carcinoma: subgroup analysis in Japanese patients from a randomized, double-blind phase II study (2016) (17)
- Risk factors for perioperative complications of laparoscopic adrenalectomy including single-site surgery. (2012) (17)
- Human castration resistant prostate cancer rather prefer to decreased 5α-reductase activity (2013) (17)
- Role of pelvic lymph node dissection in lymph node-negative patients with invasive bladder cancer. (2010) (17)
- A first Japanese case of neuroendocrine prostate cancer accompanied by lung and brain metastasis with somatic and germline BRCA2 mutation (2019) (17)
- Renin–angiotensin system blockade: Its contribution and controversy (2015) (17)
- Clinical utility of the Vesical Imaging-Reporting and Data System for muscle-invasive bladder cancer between radiologists and urologists based on multiparametric MRI including 3D FSE T2-weighted acquisitions (2020) (16)
- Prediction of extraprostatic extension by prostate specific antigen velocity, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer (2008) (16)
- Survivin associates with cell proliferation in renal cancer cells: regulation of survivin expression by insulin-like growth factor-1, interferon-gamma and a novel NF-kappaB inhibitor. (2006) (16)
- Does pelvic lymph node dissection improve the biochemical relapse-free survival in low-risk prostate cancer patients treated by laparoscopic radical prostatectomy? (2012) (16)
- Detection of circulating prostate cells during radical prostatectomy by standardized PSMA RT-PCR: association with positive lymph nodes and high malignant grade. (2003) (16)
- PKM2 under hypoxic environment causes resistance to mTOR inhibitor in human castration resistant prostate cancer (2018) (16)
- What is the most effective tool for detecting prostate cancer using a standard MR scanner? (2013) (16)
- Induction of Pluripotent Stem Cells from Primordial Germ Cells by Single Reprogramming Factors (2013) (16)
- Androgen Receptor Signaling Reduces Radiosensitivity in Bladder Cancer (2018) (16)
- Overall survival of first‐line axitinib in metastatic renal cell carcinoma: Japanese subgroup analysis from phase II study (2017) (16)
- How do young residents practice laparoscopic surgical skills? (2010) (15)
- Solifenacin or mirabegron could improve persistent overactive bladder symptoms after dutasteride treatment in patients with benign prostatic hyperplasia. (2015) (15)
- Effect of a Novel Nuclear Factor-&kgr;B Activation Inhibitor on Renal Ischemia-Reperfusion Injury (2013) (15)
- Docetaxel in combination with prednisolone for hormone refractory prostate cancer. (2010) (15)
- Phosphorylated Akt up‐regulates angiotensin II type‐1 receptor expression in castration resistant prostate cancer (2011) (15)
- Coactivation of SF-1-mediated transcription of steroidogenic enzymes by Ubc9 and PIAS1. (2011) (15)
- Simple and practical nomograms for predicting the stone-free rate after shock wave lithotripsy in patients with a solitary upper ureteral stone (2017) (15)
- Prediction of PSA bounce after permanent prostate brachytherapy for localized prostate cancer (2009) (15)
- Comparison of continence outcomes of early catheter removal on postoperative day 2 and 4 after laparoscopic radical prostatectomy: a randomized controlled trial (2015) (15)
- Impact of Combined Use of Blood-based Inflammatory Markers on Patients with Upper Tract Urothelial Carcinoma Following Radical Nephroureterectomy: Proposal of a Cumulative Marker Score as a Novel Predictive Tool for Prognosis. (2015) (15)
- Advances in targeted alpha therapy for prostate cancer. (2019) (15)
- Gemcitabine and cisplatin chemotherapy induced reversible posterior leukoencephalopathy syndrome in a bladder cancer patient (2010) (14)
- Prognostic significance of high nuclear grade in patients with pathologic T1a renal cell carcinoma. (2012) (14)
- TNFAIP2 expression induces epithelial-to-mesenchymal transition and confers platinum resistance in urothelial cancer cells (2019) (13)
- Clinical value of prostate specific antigen based parameters for the detection of prostate cancer on repeat biopsy: the usefulness of complexed prostate specific antigen adjusted for transition zone volume. (2002) (13)
- Purified Protein Derivative Skin test prior to bacillus Calmette‐Guérin Therapy May have Therapeutic Impact in Patients with Nonmuscle Invasive Bladder Cancer (2018) (13)
- Intravesical dual PI3K/mTOR complex 1/2 inhibitor NVP-BEZ235 therapy in an orthotopic bladder cancer model. (2015) (13)
- Three-dimensional single-cell imaging for the analysis of RNA and protein expression in intact tumour biopsies (2020) (13)
- Japanese Case of Enzalutamide-Resistant Prostate Cancer Harboring a SPOP Mutation With Scattered Allelic Imbalance: Response to Platinum-Based Therapy. (2019) (13)
- Clinical evaluation of two consecutive UroVysion fluorescence in situ hybridization tests to detect intravesical recurrence of bladder cancer: a prospective blinded comparative study in Japan (2018) (13)
- Efficacy and safety of sorafenib for advanced renal cell carcinoma: real-world data of patients with renal impairment (2018) (13)
- Ra-223 SPECT for semi-quantitative analysis in comparison with Tc-99m HMDP SPECT: phantom study and initial clinical experience (2017) (13)
- Prognostic significance of 5-fluorouracil metabolism-relating enzymes and enhanced chemosensitivity to 5-fluorouracil by 5-chloro 2,4-dihydroxy-pyridine in urothelial carcinoma (2012) (13)
- Potent cytotoxic effect of a novel nuclear factor-kappaB inhibitor dehydroxymethylepoxyquinomicin on human bladder cancer cells producing various cytokines. (2010) (13)
- Evaluation of prostate-specific antigen density in the diagnosis of prostate cancer combined with magnetic resonance imaging before biopsy in men aged 70 years and older with elevated PSA. (2018) (13)
- Regulation of human dendritic cells by a novel specific nuclear factor-kappaB inhibitor, dehydroxymethylepoxyquinomicin. (2010) (13)
- Primary intratesticular leiomyosarcoma. (2013) (13)
- Transumbilical laparo-endoscopic single site surgery for adrenal cortical adenoma inducing primary aldosteronism: initial experience (2011) (13)
- Role of the MUC1‐C oncoprotein in the acquisition of cisplatin resistance by urothelial carcinoma (2020) (13)
- Clinical practice patterns for upper tract urothelial carcinoma: a nationwide survey in Japan. (2016) (13)
- Prolonged pneumoperitoneum time is an independent risk factor for intravesical recurrence after laparoscopic radical nephroureterectomy in upper tract urothelial carcinoma. (2017) (12)
- Subtype-specific collaborative transcription factor networks are promoted by OCT4 in the progression of prostate cancer (2021) (12)
- Therapeutic effect of intravesical administration of paclitaxel solubilized with poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate) in an orthotopic bladder cancer model (2015) (12)
- Determining When to Stop Prostate Specific Antigen Monitoring after Radical Prostatectomy: the Role of Ultrasensitive Prostate Specific Antigen (2017) (12)
- Two cases of bowel perforation associated with sunitinib treatment for renal cell carcinoma (2012) (12)
- Significance and diagnostic accuracy of renal calculi found by ultrasonography in patients with asymptomatic microscopic hematuria (2002) (12)
- Predicting the probability of significant prostate cancer in Japanese men with serum prostate‐specific antigen less than 10 ng/mL: Development of a novel pre‐biopsy nomogram (2010) (12)
- Classification of solid renal tumor with oncocytic/eosinophilic cytoplasm: is hybrid oncocytic/chromophobe renal tumor a subtype of oncocytoma, chromophobe renal cell carcinoma, or a distinct tumor entity? (2019) (12)
- Updated long‐term outcomes after carbon‐ion radiotherapy for primary renal cell carcinoma (2018) (11)
- Patient age was an independent predictor of cancer-specific survival in male patients with upper tract urothelial carcinoma treated by radical nephroureterectomy. (2016) (11)
- Low‐dose docetaxel enhances the sensitivity of S‐1 in a xenograft model of human castration resistant prostate cancer (2012) (11)
- History of Non–Muscle‐Invasive Bladder Cancer May Have a Worse Prognostic Impact in cT2‐4aN0M0 Bladder Cancer Patients Treated With Radical Cystectomy (2018) (11)
- Serum Lactate Dehydrogenase Before Nivolumab Treatment Could Be a Therapeutic Prognostic Biomarker for Patients With Metastatic Clear Cell Renal Cell Carcinoma (2019) (11)
- The benefit of laparoscopic partial nephrectomy in high body mass index patients. (2012) (11)
- Multiplexed single-cell pathology reveals the association of CD8 T-cell heterogeneity with prognostic outcomes in renal cell carcinoma (2021) (11)
- The Role of PD-1 Positivity in the Tumour Nest on Clinical Outcome in Upper Tract Urothelial Carcinoma Patients Treated with Radical Nephroureterectomy. (2018) (11)
- Frequency of tumor recurrence: a strong predictor of stage progression in initially diagnosed nonmuscle invasive bladder cancer. (2011) (11)
- PROPEL: A randomized phase III trial evaluating the efficacy and safety of olaparib combined with abiraterone as first-line therapy in patients with metastatic castration-resistant prostate cancer (mCRPC) (2019) (11)
- Benefit of laparoscopic radical nephrectomy in patients with a high BMI. (2011) (11)
- Analysis of the CLEAR study in patients (pts) with advanced renal cell carcinoma (RCC): Depth of response and efficacy for selected subgroups in the lenvatinib (LEN) + pembrolizumab (PEMBRO) and sunitinib (SUN) treatment arms. (2021) (11)
- Clinical impact of bladder biopsies with TUR-BT according to cytology results in patients with bladder cancer: a case control study (2010) (11)
- Enhanced antitumor effect of combination intravesical mitomycin C and bacillus Calmette-Guerin therapy in an orthotopic bladder cancer model. (2011) (11)
- Renal Arteriolar Injury by Salt Intake Contributes to Salt Memory for the Development of Hypertension (2014) (10)
- Establishment of the optimal follow-up schedule after radical prostatectomy. (2018) (10)
- BCG‐induced cytokine release in bladder cancer cells is regulated by Ca2+ signaling (2018) (10)
- Predicting pubic arch interference in prostate brachytherapy on transrectal ultrasonography-computed tomography fusion images (2012) (10)
- Is DHT Production by 5α-Reductase Friend or Foe in Prostate Cancer? (2014) (10)
- How can lymphocele development be prevented after laparoscopic radical prostatectomy? (2013) (10)
- Vasohibin-1 as a novel microenvironmental biomarker for patient risk reclassification in low-risk prostate cancer (2017) (10)
- Evaluation of efficacy and safety of sorafenib in kidney cancer patients aged 75 years and older: a propensity score-matched analysis (2018) (10)
- Efficacy and safety of subsequent molecular targeted therapy after immuno-checkpoint therapy, retrospective study of Japanese patients with metastatic renal cell carcinoma (AFTER I-O study) (2021) (10)
- Successful low-dose leflunomide treatment for ganciclovir-resistant cytomegalovirus infection with high-level antigenemia in a kidney transplant: A case report and literature review. (2016) (10)
- The Significance of PARP1 as a biomarker for Predicting the Response to PD-L1 Blockade in Patients with PBRM1-mutated Clear Cell Renal Cell Carcinoma. (2021) (10)
- Does laparoendoscopic single-site adrenalectomy increase surgical risk in patients with pheochromocytoma? (2013) (10)
- Clinicopathological Features Predicting Nodal Metastasis of Testicular Seminoma: Results from 100 Cases in a Single Institute (2006) (10)
- Differential expression of activator protein-2 isoforms in renal cell carcinoma. (2004) (10)
- Purified protein derivative skin test reactions are associated with clinical outcomes of patients with nonmuscle invasive bladder cancer treated with induction bacillus Calmette-Guérin therapy. (2018) (10)
- No significant impact of patient age and prior treatment profile with docetaxel on the efficacy of cabazitaxel in patient with castration-resistant prostate cancer (2018) (10)
- Color Doppler Ultrasound Evaluation of Ureteral Jet Angle to Detect Vesicoureteral Reflux in Children. (2016) (10)
- The learning curve of laparoendoscopic single-site adrenalectomy: an analysis of over 100 cases (2016) (10)
- Myasthenia gravis with myositis induced by pembrolizumab therapy in a patient with metastatic urothelial carcinoma (2020) (9)
- CD8-positive T cells and CD204-positive M2-like macrophages predict postoperative prognosis of very high-risk prostate cancer (2021) (9)
- Preoperative sarcopenia status is associated with lymphovascular invasion in upper tract urothelial carcinoma patients treated with radical nephroureterectomy. (2017) (9)
- Prediction of extraprostatic extension by MRI tumor contact length: difference between anterior and posterior prostate cancer (2019) (9)
- What is the predictor of prolonged operative time during laparoscopic radical prostatectomy? (2013) (9)
- Sunitinib versus sorafenib as first-line therapy for patients with metastatic renal cell carcinoma with favorable or intermediate MSKCC risk factors: A multicenter randomized trial, CROSS-J-RCC. (2014) (9)
- Sunitinib Versus Sorafenib as Initial Targeted Therapy for mCC-RCC With Favorable/Intermediate Risk: Multicenter Randomized Trial CROSS-J-RCC. (2020) (9)
- Renal cell carcinoma in patients with acquired cystic disease of the kidney: Assessment using a combination of T2‐weighted, diffusion‐weighted, and chemical‐shift MRI without the use of contrast material (2014) (9)
- Can urologists introduce the concept of “oligometastasis” for metastatic bladder cancer after total cystectomy? (2017) (9)
- Obstructive sleep apnea syndrome should be considered as a cause of nocturia in younger patients without other voiding symptoms. (2016) (9)
- Radiological findings of primary localized amyloidosis of the ureter (2012) (9)
- Metastatic urothelial carcinoma to pericardia manifested by dyspnea from cardiac tamponade during systemic chemotherapy: Case report and literature review. (2012) (9)
- Long-Term Oncologic Outcomes of Laparoscopic Versus Open Radical Nephroureterectomy for Patients with T3N0M0 Upper Tract Urothelial Carcinoma: A Multicenter Cohort Study with Adjustment by Propensity Score Matching (2019) (9)
- Optimal treatment strategy for paratesticular liposarcoma: retrospective analysis of 265 reported cases (2020) (8)
- Castration-resistant prostate cancer patients who had poor response on first androgen deprivation therapy would obtain certain clinical benefit from early docetaxel administration (2019) (8)
- Hemorrhagic cystitis in a patient without a past history of radiation therapy who was treated with cabazitaxel for CRPC. (2015) (8)
- Asia prostate cancer study (A-CaP Study) launch symposium (2016) (8)
- Landscape of prognostic signatures and immunogenomics of the AXL/GAS6 axis in renal cell carcinoma (2021) (8)
- Author Correction: MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer (2020) (8)
- Usefulness of alpha1-antichymotrypsin-PSA complex for predicting bone metastases of prostate cancer. (2006) (8)
- Selection of patients who would not require long-term prostate-specific antigen monitoring after low-dose-rate brachytherapy. (2018) (8)
- A clinical study to evaluate the efficacy and safety of docetaxel with ribavirin in patients with progressive castration resistant prostate cancer who have previously received docetaxel alone. (2017) (8)
- Headache Caused by Brain Metastases of Castration-resistant Prostate Cancer during Cabazitaxel Therapy. (2017) (8)
- Performance of diffusion-weighted MRI post-CT urography for the diagnosis of upper tract urothelial carcinoma: Comparison with selective urine cytology sampling. (2018) (8)
- Cabozantinib in advanced renal cell carcinoma: A phase II, open‐label, single‐arm study of Japanese patients (2020) (8)
- Impact of Second-Line Targeted Therapy Dose Intensity on Patients With Metastatic Renal Cell Carcinoma. (2016) (8)
- Lymphovascular invasion status at transurethral resection of bladder tumors may predict subsequent poor response of T1 tumors to bacillus Calmette-Guérin (2016) (8)
- Prospective clinical trial of 12-fraction carbon-ion radiotherapy for primary renal cell carcinoma (2019) (8)
- A multicenter phase I/II study of enzalutamide in Japanese patients with castration-resistant prostate cancer (2016) (8)
- A Novel Risk-based Approach Simulating Oncological Surveillance After Radical Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma. (2020) (8)
- Aggressive prostate cancer with somatic loss of the homologous recombination repair gene FANCA: a case report (2020) (8)
- Modulation of bcl-2 family proteins in MAPK independent apoptosis induced by a cdc25 phosphatase inhibitor Cpd 5 in renal cancer cells. (2005) (8)
- Periprostatic fat area is an independent factor that prolonged operative time in laparoscopic radical prostatectomy. (2013) (8)
- Does neoadjuvant chemotherapy have therapeutic benefit for node-positive upper tract urothelial carcinoma? Results of a multi-center cohort study. (2021) (7)
- Preserved Kidney Volume, Body Mass Index, and Age Are Significant Preoperative Factors for Predicting Estimated Glomerular Filtration Rate in Living Kidney Donors at 1 Year After Donation. (2019) (7)
- Three‐dimensional ultrasonography in evaluation of benign prostatic hyperplasia (2004) (7)
- Significance of a frozen section analysis of the ureteral margin in bladder cancer patients treated with radical cystectomy and neoadjuvant chemotherapy (2017) (7)
- Clinical efficacy and prognostic factors of tumor progression in Japanese patients with advanced renal cell carcinoma treated with sorafenib. (2015) (7)
- Biochemical Modulation of 5‐Fluorouracil with Murine Interferon‐α/β Against Murine Renal Cell Carcinoma (1997) (7)
- Factors influencing the operating time for single-port laparoscopic radical nephrectomy: focus on the anatomy and distribution of the renal artery and vein (2017) (7)
- Potent increased risk of the initiation of DNA replication in human prostate cancer with the use of 5α-reductase inhibitors. (2014) (7)
- Follicle-stimulating hormone enhances recovery from low-dose doxorubicin-induced spermatogenic disorders in mice (2015) (7)
- Discovery of a new candidate drug to overcome cabazitaxel-resistant gene signature in castration-resistant prostate cancer by in silico screening (2021) (7)
- Limited in vitro efficacy of CYP17A1 inhibition on human castration resistant prostate cancer (2014) (7)
- Unique characteristics of tertiary lymphoid structures in kidney clear cell carcinoma: prognostic outcome and comparison with bladder cancer (2022) (7)
- Antitumor effect of interleukin-2 entrapped in liposomes on murine renal cell carcinoma. (1994) (7)
- Sunitinib versus sorafenib as first-line therapy followed by sorefenib and sunitinib for patients with metastatic renal cell carcinoma (RCC) with clear cell histology: A multicenter randomized trial, CROSS-J-RCC. (2017) (7)
- MUC1-C integrates type II interferon and chromatin remodeling pathways in immunosuppression of prostate cancer (2022) (7)
- Prostate brachytherapy seed migration to a left varicocele. (2012) (7)
- Pre-donation BMI and preserved kidney volume can predict the cohort with unfavorable renal functional compensation at 1-year after kidney donation (2019) (6)
- Renal cell carcinoma: relevance of pathology (2003) (6)
- Proton pump inhibitors may hinder hypophosphatemic effect of lanthanum carbonate, but not of ferric citrate hydrate or sucroferric oxyhydroxide, in hemodialysis patients (2020) (6)
- Mutation of GALNTL5 gene identified in patients diagnosed with asthenozoospermia (2020) (6)
- Application of the Interferon Minipellet to Human Renal Cell Carcinoma in Nude Mice (1997) (6)
- Successful Treatment of Anti-MDA5 Antibody-Positive Dermatomyositis-Associated Rapidly Progressive-Interstitial Lung Disease by Plasma Exchange: Two Case Reports (2021) (6)
- Therapeutic enhancement of S-1 with CPT-11 through down-regulation of thymidylate synthase in bladder cancer (2013) (6)
- Preimplant factors affecting postimplant CT-determined prostate volume and the CT/TRUS volume ratio after transperineal interstitial prostate brachytherapy with 125I free seeds (2010) (6)
- Optimal timing of hormonal therapy for prostate-specific antigen recurrence after radical prostatectomy (2014) (6)
- Type of patients in whom biochemical recurrence after radical prostatectomy can be observed without salvage therapy (2019) (6)
- Significance of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer. (2020) (6)
- A prospective longitudinal survey of erectile function status in symptomatic benign prostatic hyperplasia patients treated with dutasteride (2016) (6)
- The clinical impact of the classification of carcinoma in situ on tumor recurrence and their clinical course in patients with bladder tumor. (2011) (6)
- PROPEL: A randomized, phase III trial evaluating the efficacy and safety of olaparib combined with abiraterone as first-line therapy in patients with metastatic castration-resistant prostate cancer (mCRPC). (2019) (6)
- Technical Improvement Using a Three-Dimensional Video System for Laparoscopic Partial Nephrectomy. (2016) (6)
- Effect of reclassification of the IMDC model in patients with metastatic renal cell carcinoma treated with targeted therapy in the first-line and second-line settings. (2016) (6)
- Clinical Background of Patients with Sperm in Their Urinary Sediment (2015) (5)
- Characterizing intermediate-risk non-muscle-invasive bladder cancer: Implications for the definition of intermediate risk and treatment strategy. (2017) (5)
- Influence of dutasteride treatment on serum hormone levels and aging male symptoms in patients with benign prostatic enlargement (2018) (5)
- Are the Formulas Used to Estimate Renal Function Adequate for Patients Treated With Cisplatin-Based Chemotherapy After Nephroureterectomy for Upper Tract Urothelial Carcinoma? (2016) (5)
- Efficacy of avelumab plus axitinib (A + Ax) versus sunitinib (S) by number of IMDC risk factors and tumor sites at baseline in advanced renal cell carcinoma (aRCC): Extended follow-up results from JAVELIN Renal 101. (2021) (5)
- The efficacy of the TachoSil binding suturing technique in laparoscopic partial nephrectomy to prevent the development of pseudoaneurysm. (2020) (5)
- Immunoglobulin G4-Related Disease Arising from the Bladder Wall (2018) (5)
- Role of Previous Malignancy History in Clinical Outcomes in Patients with Initially Diagnosed Non-Muscle Invasive Bladder Cancer (2021) (5)
- A Case of Gemcitabine and Cisplatin Chemotherapy in a Patient With Metastatic Urothelial Carcinoma Receiving Hemodialysis. (2016) (5)
- Efficacy and safety of darolutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a sub-group analysis of the phase III ARAMIS trial (2020) (5)
- Patients with metastatic renal cell carcinoma who benefit from axitinib dose titration: analysis from a randomised, double-blind phase II study (2019) (5)
- Clinical Outcomes in Patients With Metastatic Papillary Renal‐Cell Carcinoma: A Multi‐Institutional Study in Japan (2018) (5)
- Accidental Hypothermia Treated by Hemodialysis in the Acute Phase: Three Case Reports and a Review of the Literature (2019) (5)
- Cost analysis of leuprorelin acetate in Japanese prostate cancer patients: comparison between 6-month and 3-month depot formulations (2017) (5)
- Enzalutamide + androgen deprivation therapy (ADT) versus flutamide + ADT in Japanese men with castration‐resistant prostate cancer: AFTERCAB study (2021) (5)
- Risk stratification of castration-resistant prostate cancer patients treated with cabazitaxel. (2018) (5)
- Repeated regression of pulmonary metastases from renal cell carcinoma after treatment using different interferon-alpha preparations. (2005) (5)
- Ureteral metastasis from prostate cancer (2014) (5)
- Urinary pH Levels are Strongly Associated with Bladder Recurrence After Nephroureterectomy in Upper Tract Urothelial Carcinoma Patients with a Smoking History (2016) (5)
- Imaging features of renal cell carcinoma differential diagnosis, staging, and posttreatment evaluation (2017) (5)
- The clinicopathological characteristics of muscle‐invasive bladder recurrence in upper tract urothelial carcinoma (2020) (5)
- Impact of pegfilgrastim as primary prophylaxis for metastatic castration-resistant prostate cancer patients undergoing cabazitaxel treatment: an open-label study in Japan (2019) (5)
- Evaluating the Oncological Outcomes of Pure Laparoscopic Radical Nephroureterectomy Performed for Upper-Tract Urothelial Carcinoma Patients: A Multicenter Cohort Study Adjusted by Propensity Score Matching (2020) (5)
- Prognostic value of serum C-reactive protein level prior to second-line treatment in intermediate risk metastatic renal cell carcinoma patients (2019) (5)
- The prognostic value of zonal origin and extraprostatic extension of prostate cancer for biochemical recurrence after radical prostatectomy. (2019) (5)
- GENITOURINARY CANCERS (2007) (5)
- Efficacy of treatment with a GnRH antagonist in prostate cancer patients previously treated with a GnRH agonist (2015) (4)
- Prognostic significance of erythrocyte protein band 4.1-like5 expression in upper urinary tract urothelial carcinoma. (2017) (4)
- Abstracts of Oral Presentations (2008) (4)
- Are predictive models for cancer volume clinically useful in localized prostate cancer? (2009) (4)
- THE EFFECT OF A NOVEL NUCLEAR FACTOR KAPPAB ACTIVATION INHIBITOR ON RENAL INFLAMMATORY RESPONSES IN RATS WITH RENAL ISCHEMIA REPERFUSION INJURY: 1630 (2010) (4)
- ETS-1 AND HYPOXIA INDUCIBLE FACTOR-1 α INDUCED BY ANGIOTENSIN II: NOVEL NEW MOLECULAR TARGETS OF ANGIOTENSINII TYPE-1 RECEPTOR BLOCKER (ARB) AS AN ANGIOGENIC INHIBITOR (2009) (4)
- Small intestinal perforation due to a huge gastrointestinal stromal tumor in a kidney transplant recipient: a case report and literature review (2019) (4)
- Should We Try Antiandrogen Withdrawal in Castration-Resistant Prostate Cancer Patients? Insights From a Retrospective Study. (2016) (4)
- Usefulness of contrast-enhanced ultrasonography for diagnosis of renal cell carcinoma in dialysis patients (2019) (4)
- A case of spinal and bulbar muscular atrophy with high-stage and high-Gleason Score prostate cancer responded to maximal androgen blockade therapy. (2012) (4)
- Patients with metastatic renal cell carcinoma who have benefit from axitinib dose titration: Analysis from a randomized, double-blind, axitinib dose titration phase II study. (2017) (4)
- [A questionnaire survey of antimicrobial prophylaxis to prevent perioperative infection in urological field in Japan]. (2013) (4)
- Evaluation of Gleason Grade Group 5 in a Contemporary Prostate Cancer Grading System and Literature Review. (2020) (4)
- 307 BISEBROMOAMIDE, AS A NOVEL MOLECULAR TARGET DRUG INHIBITING PHOSPHORYLATION OF BOTH EXTRACELLULAR SIGNAL-REGULATED KINASE AND AKT IN RENAL CELL CARCINOMA (2012) (4)
- Three cases of granulocyte colony-stimulating factor-producing urinary upper tract carcinomas (2012) (4)
- Biopsy-diagnosed renal granuloma after intravesical bacillus Calmette-Guérin therapy for bladder carcinoma: a case series and review of the literature (2019) (4)
- Safety and efficacy of plasma exchange via direct femoral vein puncture in autoimmune blistering diseases (2020) (4)
- Landscape of genomic alterations of circulating tumor DNA in advanced genitourinary cancer patients: SCRUM-Japan MONSTAR SCREEN Project. (2021) (4)
- Little Impact on Renal Function in Advanced Renal Cell Carcinoma Patients Treated with Sorafenib--Analyses of Postmarketing Surveillance in Japan in over 3,200 Consecutive Cases. (2016) (4)
- Subgroup analysis of the AFTER I-O study: a retrospective study on the efficacy and safety of subsequent molecular targeted therapy after immune-oncology therapy in Japanese patients with metastatic renal cell carcinoma (2021) (4)
- Significance of tumor microenvironment in acquiring resistance to vascular endothelial growth factor‐tyrosine kinase inhibitor and recent advance of systemic treatment of clear cell renal cell carcinoma (2020) (4)
- Does switching the bacillus Calmette-Guérin strain affect clinical outcome in patients with recurrent non-muscle-invasive bladder cancer after initial bacillus Calmette-Guérin therapy? (2018) (4)
- Risk factors for haemodynamic instability and its prolongation during laparoscopic adrenalectomy for pheochromocytoma (2021) (3)
- Appropriate timing for a biochemical evaluation after adrenalectomy for unilateral aldosterone‐producing adenoma (2020) (3)
- Prostate‐specific antigen nadir within 12 months as an early surrogate marker of biochemical failure and distant metastasis after low‐dose‐rate brachytherapy or external beam radiotherapy for localized prostate cancer (2018) (3)
- Visceral to total obesity ratio and severe hydronephrosis are independently associated with prolonged pneumoperitoneum operative time in patients undergoing laparoscopic radical nephroureterectomy for upper tract urothelial carcinoma (2015) (3)
- 1165 NOVEL ALGORITHM FOR PREDICTING SEVERE CASES OF ACUTE BACTERIAL PROSTATITIS (2013) (3)
- Grading of Multifocal Prostate Cancer Cases in which the Largest Volume and the Highest Grade do Not Coincide within One Lesion. (2021) (3)
- Natural course of asymptomatic abnormal prostate findings incidentally detected by CT after intravesical BCG therapy (2017) (3)
- Biochemical modulation of 5-fluorouracil with murine interferon-alpha/beta against murine renal cell carcinoma. (1997) (3)
- Prognostic stratification in patients who received hormonal therapy for prostate-specific antigen recurrence after radical prostatectomy. (2010) (3)
- Urinary pH is an independent predictor of upper tract recurrence in non-muscle-invasive bladder cancer patients with a smoking history (2021) (3)
- Synthetic magnetic resonance imaging for primary prostate cancer evaluation: Diagnostic potential of a non-contrast-enhanced bi-parametric approach enhanced with relaxometry measurements (2022) (3)
- Spontaneous Regression of Epstein-Barr Virus-Positive Primary Diffuse Large Cell B-Cell Lymphoma of the Urinary Bladder After the Cessation of Enzalutamide. (2016) (3)
- Novel algorithm for management of acute epididymitis (2017) (3)
- Cranial nerve palsy caused by metastasis to the skull base in patients with castration‐resistant prostate cancer: Three case reports (2021) (3)
- Renal hemorrhage caused by acquired inhibitors to coagulation factors VIII and V in a hemodialysis patient (2016) (3)
- A phase 1/2a trial of docetaxel plus ribavirin for reprogramming efficacy in patients with progressive metastatic castration resistant prostate cancer who have previously received docetaxel alone: DRREEM trial. (2018) (3)
- TUMOR NECROSIS IS AN INDICATOR OF AGGRESSIVE BIOLOGY IN PATIENTS WITH UROTHELIAL CARCINOMA OF THE UPPER URINARY TRACT (2009) (3)
- Evaluation of histopathological findings at the injection site following degarelix administration (2015) (3)
- Diagnostic value of texture analysis of apparent diffusion coefficient maps for differentiating fat-poor angiomyolipoma from non-clear-cell renal cell carcinoma. (2021) (3)
- Diagnostic performance of the vesical imaging-reporting and data system for detecting muscle-invasive bladder cancer in real clinical settings: Comparison with diagnostic cystoscopy. (2021) (3)
- GSK-3 IS A POTENTIAL THERAPEUTIC TARGET FOR THE TREATMENT OF RENAL CELL CARCINOMA (RCC): PRECLINICAL IN VITRO AND IN VIVO INVESTIGATION (2009) (3)
- External validation of the "optimal PSA follow-up schedule after radical prostatectomy” in a new cohort (2020) (3)
- Transumbilical laparoendoscopic single-site partial nephrectomy using a microwave tissue coagulator (2012) (3)
- Clinical implications of tumor size and local extent of primary prostatic lesions in prostate cancer patients with metastases: value of endorectal magnetic resonance imaging in patients with metastases. (2007) (3)
- Impact of inflammatory marker levels one month after the first-line targeted therapy initiation on progression-free survival prediction in patients with metastatic clear cell renal cell carcinoma (2018) (3)
- Pulmonary metastasis secondary to abiraterone‐resistant prostate cancer with homozygous deletions of BRCA2: First Japanese case (2020) (3)
- Prominent response to platinum‐based chemotherapy in a patient with BRCA2 mutant‐neuroendocrine prostate cancer and MDM2 amplification (2021) (3)
- Optimal surgical treatment for paratesticular leiomyosarcoma: retrospective analysis of 217 reported cases (2022) (3)
- Real-world use of sorafenib for advanced renal cell carcinoma patients with cardiovascular disease: nationwide survey in Japan (2020) (3)
- Complete response with early introduction of cabazitaxel in a patient with multiple lung metastases of castration-resistant prostate cancer following the early detection of metastases using liquid biopsy: a case report (2019) (3)
- Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma (2021) (3)
- Overall survival analysis from a randomized phase II study of axitinib with or without dose titration for first-line metastatic renal cell carcinoma. (2015) (3)
- Androgen deprivation therapy improves pneumoperitoneum time during laparoscopic radical prostatectomy in Japanese patients with enlarged prostates (2014) (3)
- A Japanese patient with ductal carcinoma of the prostate carrying an adenomatosis polyposis coli gene mutation: a case report (2020) (3)
- Utility of radiomics features of diffusion-weighted magnetic resonance imaging for differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma: model development and external validation (2022) (3)
- Non-muscle invasive bladder cancer with concomitant vaginal urothelial carcinoma: a case report and review of the literature (2010) (3)
- Preimplant factors affecting prostate D90 after transperineal interstitial prostate brachytherapy with loose (125)I seeds. (2012) (3)
- [Recurrence of bladder cancer in remnant urethra and inguinal lymph node metastasis nine years after total cystectomy: a case report]. (2011) (3)
- Dual Phosphatidylinositol-3-Kinase / Mammalian Target of Rapamycin Inhibitor NVP-BEZ 235 Sensitizes Docetaxel in Castration Resistant Prostate Cancer (2013) (3)
- Pharmacokinetics and Antitumor Effects of an Interleukin‐2 lmmunocomplexing Agent in Murine Renal Cell Carcinoma (1996) (3)
- Real-world use of temsirolimus in Japanese patients with unresectable or metastatic renal cell carcinoma: recent consideration based on the results of a post-marketing, all-case surveillance study (2020) (3)
- A case of inguinal cellular angiofibroma (2020) (3)
- Final overall survival (OS) in PROpel: Abiraterone (abi) and olaparib (ola) versus abiraterone and placebo (pbo) as first-line (1L) therapy for metastatic castration-resistant prostate cancer (mCRPC). (2023) (2)
- Erratum: Occurrence of infection following prostate biopsy procedures in Japan: Japanese Research Group for Urinary Tract Infection (JRGU) - A multi-center retrospective study (Journal of Infection and Chemotherapy (2014) 20 (232-237)) (2014) (2)
- Syndrome of inappropriate antidiuretic hormone secretion in a patient with castration-resistant prostate cancer treated with enzalutamide (2016) (2)
- A pooled analysis of the efficacy and safety of cabozantinib post immunotherapy in patients with advanced renal cell carcinoma. (2020) (2)
- A first case of ductal adenocarcinoma of the prostate having characteristics of neuroendocrine phenotype with PTEN, RB1 and TP53 alterations (2021) (2)
- Dehydroxymethylepoxyquinomicin, a novel nuclear factor-κB inhibitor, prevents the development of cyclosporine A nephrotoxicity in a rat model (2020) (2)
- Profiling the Biological Characteristics and Transitions through Upper Tract Tumor Origin, Bladder Recurrence, and Muscle-Invasive Bladder Progression in Upper Tract Urothelial Carcinoma (2022) (2)
- A Case of New-Onset Systemic Lupus Erythematosus With Serositis in a Maintenance Hemodialysis Patient (2021) (2)
- IDH2 stabilizes HIF‐1α‐induced metabolic reprogramming and promotes chemoresistance in urothelial cancer (2023) (2)
- Can random bladder biopsies be eliminated after bacillus Calmette–Guérin therapy against carcinoma in situ? (2020) (2)
- Functional analysis of GCNT3 for cell migration and EMT of castration-resistant prostate cancer cells. (2022) (2)
- Development of a novel interferon-α2b gene construct with a repetitive hypoxia-inducible factor binding site and its suppressive effects on human renal cell carcinoma cell lines in vitro (2013) (2)
- Brain metastasis of a papillary renal cell carcinoma, identified as type 2 (2009) (2)
- Deep Learning Algorithm for Fully Automated Detection of Small (≤4 cm) Renal Cell Carcinoma in Contrast-Enhanced Computed Tomography Using a Multicenter Database (2021) (2)
- 597 EXPRESSION OF SNAIL IN UPPER URINARY TRACT UROTHELIAL CARCINOMA: PROGNOSTIC SIGNIFICANCE AND IMPLICATIONS FOR TUMOR INVASION (2011) (2)
- MP16-18 DEVELOPMENT OF AN ALGORITHM FOR PREDICTING SEVERE ACUTE EPIDIDYMITIS (2014) (2)
- An organ-derived extracellular matrix triggers in situ kidney regeneration in a preclinical model (2022) (2)
- Dexamethasone and interleukin‐2 combination therapy for advanced renal cell carcinoma in a patient with paraneoplastic inflammatory syndrome (2004) (2)
- [Clinical characteristics and outcomes of congenital midureteral stricture detected by fetal ultrasonography]. (2014) (2)
- PSA CUT-OFF NOMOGRAM THAT AVOID OVER-DETECTION OF PROSTATE CANCER IN ELDERLY MEN (2009) (2)
- Factors affecting renal function preservation among patients not achieving trifecta after laparoscopic partial nephrectomy for clinical T1a renal masses (2019) (2)
- Erectile function recovery at 12 months after radical prostatectomy for prostate cancer is not associated with overall survival (2019) (2)
- Brachytherapy seeds as a nidus for urethral stone formation: A case report (2019) (2)
- Effects of transurethral resection under general anesthesia on tumor recurrence in non-muscle invasive bladder cancer (2021) (2)
- Complete Response to Bicalutamide Withdrawal Prolonged for Almost 2 Years in Patients With Metastatic Prostate Cancer☆ (2014) (2)
- 1153: Prediction of Extraprostatic Cancer by Serum [-2] PRO Prostate Specific Antigen in Clinically Localized Prostate Cancer (2007) (2)
- Publisher Correction: Whole-tissue biopsy phenotyping of three-dimensional tumours reveals patterns of cancer heterogeneity (2018) (2)
- [Three cases of IgG4-related disease associated with urinary tract obstruction]. (2013) (2)
- Relationship between radiation doses and erectile function deterioration in patients with localized prostate cancer treated with permanent prostate brachytherapy (2020) (2)
- Is transperitoneal laparoscopic radical nephrectomy suitable for patients with a history of abdominal surgery? (2018) (2)
- Baseline risk stratification or duration of prior therapy predicts prognosis in patients with metastatic renal cell carcinoma treated with axitinib (2017) (2)
- Development of testicular alpha-fetoprotein-secreting germ cell tumor 3 years after treatment of intracranial lesion identified as non-secreting germ cell tumor on the basis of clinical data--case report. (2008) (2)
- Retroperitoneal Ewing's sarcoma. (1995) (2)
- Physical Parameters, Use of Specific Medical Treatments, Nursing Levels, and Activities of Daily Living Are Potential Indicators for Forgoing Maintenance Hemodialysis. (2019) (2)
- Predictors of urinary function recovery after laparoscopic and robot-assisted radical prostatectomy (2022) (2)
- Characteristics and management of erectile dysfunction after various treatments for prostate cancer (2010) (2)
- Influence of physician years on urological journal publication productivity among Japanese urologists (2016) (2)
- First successful case of platinum‐based chemotherapy for neuroendocrine prostate cancer with BRCA2 and PTEN alterations (2021) (2)
- Germline BRCA2 mutation in a case of aggressive prostate cancer accompanied by spinal bulbar muscular atrophy (2021) (2)
- Comparing the oncological outcomes between pure laparoscopic radical nephroureterectomy and laparoscopic assisted nephroureterectomy for upper-tract urothelial carcinoma: A multi-center cohort study adjusted by propensity score matching (2020) (2)
- Multiple metastases of androgen indifferent prostate cancer in the urinary tract: two case reports and a literature review (2022) (2)
- 897 IMPACT OF SMOKING STATUS ON BLADDER RECURRENCE FOLLOWING RADICAL NEPHROURETERECTOMY IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA (2013) (2)
- Rare association of the anterior and posterior urethral valves (2018) (2)
- Amiodarone-induced multiple organ damage in an Alström syndrome patient with end-stage renal disease and hepatic cirrhosis (2021) (2)
- [Treatment of renal cell carcinoma with interferons]. (2006) (2)
- Continuous use of enzalutamide in a patient who developed enzalutamide-induced thrombocytopenia (2015) (1)
- Efficacy and safety of abiraterone acetate (AA) and low-dose prednisone (P) in Japanese patients with newly diagnosed, metastatic, hormone-naïve prostate cancer (mHNPC): Subgroup analysis of LATITUDE trial. (2018) (1)
- A case of paraneoplastic liver dysfunction with elevated serum interleukin-6 in clinically localized renal cell carcinoma (2015) (1)
- Age at diagnosis on prostate cancer survival undergoing androgen deprivation therapy as primary treatment in daily practice: results from Japanese observational cohort (2014) (1)
- MP29-05 PROGNOSTIC SIGNIFICANCE OF TNF-α AND CD44 EXPRESSION IN CLEAR CELL RENAL CELL CARCINOMAS: IMPLICATION OF CANCER INVASION, METASTASIS, AND RESISTANCE TO SUNITINIB TREATMENT (2014) (1)
- Three-dimensional conformal arc radiotherapy using a C-arm linear accelerator with a computed tomography on-rail system for prostate cancer: clinical outcomes (2015) (1)
- Therapeutic effect of intravesical administration of paclitaxel solubilized with poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate) in an orthotopic bladder cancer model (2015) (1)
- MP27-02 PROGNOSTIC ROLE OF PROGRAMMED CELL DEATH PROTEIN 1 EXPRESSION IN SURGICALLY TREATED PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA. (2016) (1)
- Perimortem changes in clinical parameters in patients undergoing maintenance hemodialysis (2021) (1)
- Activity of axitinib in patients with metastatic renal cell carcinoma previously treated with both vascular endothelial growth factor receptor tyrosine‐kinase inhibitor and mammalian target of rapamycin inhibitor (2014) (1)
- MP03-03 METASTATIC RENAL CELL CARCINOMA TO THE BLADDER: SYSTEMATIC REVIEW OF 113 REPORTED CASES (2016) (1)
- Castration-resistant prostate cancer patient presenting with whole genome doubling with CDK-12 mutation (2022) (1)
- Suprapubic cystostomy and vesicocutaneostomy (2016) (1)
- Efficacy of axitinib in patients with metastatic renal cell carcinoma previously treated with both VEGFR-TKI and mTORI. (2014) (1)
- Renal cell carcinoma arising from a horseshoe kidney in a chronic hemodialysis patient (2012) (1)
- Oncological outcomes of dose reductions in cisplatin due to renal dysfunction for patients with metastatic urothelial carcinoma (2021) (1)
- Investigation of the management and risk of febrile neutropenia associated with chemotherapy in the urological field: A multicenter, retrospective analysis (2014) (1)
- RENAL INTERSTITIAL FIBROSIS, TUBULAR APOPTOSIS, AND INFLAMMATORY RESPONSE ARE INHIBITED IN MICE LACKING THE ANGIOTENSINOGEN GENE AND SUBJECTED TO UNILATERAL URETERAL OBSTRUCTION (2008) (1)
- Tolerability of abiraterone (abi) combined with olaparib (ola) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Further results from the phase III PROpel trial. (2022) (1)
- The first Japanese case of intraductal cancer of the prostate with checkpoint kinase 2 mutation (2022) (1)
- A Case of Bladder-Inverted Papilloma after Brachytherapy for Prostate Cancer (2014) (1)
- Metastatic type-2 papillary renal cell carcinoma responded to interleukin-2 therapy: case report (2008) (1)
- Erectile function status is highly associated with prostate‐specific antigen bounce in localized prostate cancer patients treated with permanent prostate brachytherapy (2016) (1)
- A low subcutaneous fat mass is a risk factor for the development of inguinal hernia after radical prostatectomy (2022) (1)
- Down-regulation of NF kappa B activation is an effective therapeutic modality in acquired platinum-resistant bladder cancer (2015) (1)
- A metastatic castration resistant prostate cancer patient with multiple bone metastases has durable biochemical and radiological response to docetaxel chemotherapy. (2016) (1)
- Germline Whole-Gene Deletion of FH Diagnosed from Tumor Profiling (2021) (1)
- [Risk Classification and Nivolumab plus Ipilimumab Combination Therapy for Treatment of Renal Cell Carcinoma]. (2019) (1)
- Efficacy and safety of gemcitabine monotherapy in an elderly patient with penile metastasis from bladder carcinoma: a case report (2013) (1)
- Efficacy and safety of docetaxel-based chemotherapy in Japanese men over 80 years old with castration-resistant prostate cancer. (2013) (1)
- 242 The predictive value of C-reactive protein on prognosis of patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: Multi-institutional study (2013) (1)
- Topoisomerase II alpha inhibition can overcome taxane-resistant prostate cancer through DNA repair pathways (2021) (1)
- Characterization of Aldosterone-producing Cell Cluster (APCC) at Single-cell Resolution (2022) (1)
- First case of ductal adenocarcinoma of the prostate with MAP3K1 homozygous deletion (2020) (1)
- Extensive disease among potential candidates for hemi‐ablative focal therapy for prostate cancer (2019) (1)
- Biomarkers Towards New Era of Therapeutics for Metastatic Renal Cell Carcinoma (2020) (1)
- A Case of Bladder Cancer after Radiation Therapy for Prostate Cancer (2014) (1)
- MP34-01 NICOTINE INDUCES TUMOR AGGRESSIVENESS AND CHEMORESISTANCE THROUGH ACTIVATION OF PI3K/AKT/MTOR PATHWAY IN BLADDER CANCER (2014) (1)
- Editorial Comment to How to prepare and present scientific manuscripts in English (2013) (1)
- Renal damage inhibited in mice lacking angiotensinogen gene subjected to unilateral ureteral obstruction. (2009) (1)
- Proceedings of The 28th Annual Meeting of the Japan Human Cell Society 23 August 2009 Tsukuba, Ibaraki, Japan (2010) (1)
- Incidence and location of perioperative deep vein thrombosis in patients with bladder cancer undergoing radical cystectomy (2021) (1)
- Placebo-Induced Severe Diarrhea in a Patient With Metastatic Castration-Resistant Prostate Cancer Participating in a Double-Blind, Randomized, Phase III International Trial. (2016) (1)
- Hybridisation chain reaction-based visualisation and screening for lncRNA profiles in clear-cell renal-cell carcinoma (2022) (1)
- 1551: Clinical Value of Diffusion-Weighted Imaging and Dynamic MRI in Combination with T2W Imaging for the Detection of Prostate Cancer (2006) (1)
- Renal cell carcinoma accompanied by left-sided IVC. (2011) (1)
- A Japanese case of castration-resistant prostate cancer with BRCA2 and RB1 co-loss and TP53 mutation: a case report (2022) (1)
- Application of Cytokine Drug Delivery Systems to the Immunotherapy of Renal Cell Carcinoma in Mice (1996) (1)
- Coincident detection of lung metastasis of prostate cancer and primary lung cancer: A case report. (2015) (1)
- Successful Treatment of End-stage Renal Disease in a Patient With Chronic Myeloid Leukemia by Kidney Transplantation and Tyrosine Kinase Inhibitors: A Case Report. (2020) (1)
- MP18-05 NOVEL PROGNOSTIFICATION MODEL FOR CLEAR CELL RENAL CELL CARCINOMA (2020) (1)
- Site-Specific Differences in PD-1 Blockade Success and Biomarkers in Urothelial Carcinoma Treated with Pembrolizumab. (2022) (1)
- 609 COLOR DOPPLER SONOGRAPHIC EVALUATION OF URETERIC JET ANGLE IN DETECTING HIGH GRADE VESICOURETERAL REFLUX IN CHILDREN (2012) (1)
- Individualized prostate-specific antigen threshold values to avoid overdiagnosis of prostate cancer and reduce unnecessary biopsy in elderly men. (2014) (1)
- MP35-20 PLASMA FIBRINOGEN LEVEL INDEPENDENTLY PREDICTS THE PROGNOSIS OF PATIENTS WITH NON-METASTATIC RENAL CELL CARCINOMA (2015) (1)
- Hormonal therapy for localized prostate cancer in Japan: The outcome of J-CaP database. (2012) (1)
- PROPOSAL FOR SUBCLASSIFICATION OF PT3 UROTHELIAL CANCER OF THE RENAL PELVIS (2009) (1)
- 1768 CLINICAL SIGNIFICANCE OF THE CLASSIFICATION FOR BACILLUS CALMETTE-GUÉRIN FAILURE IN NON-MUSCLE INVASIVE BLADDER CANCERS (2012) (1)
- The prevalence of gene mutations in homologous recombination repair pathways in Japanese patients with metastatic castration‐resistant prostate cancer in real‐world clinical practice: The multi‐institutional observational ZENSHIN study (2022) (1)
- Clinically complete response to abiraterone acetate in a patient with metastatic castration‐resistant prostate cancer (2019) (1)
- Utility of prophylactic antibiotics for preventing febrile neutropenia during cabazitaxel therapy for castration-resistant prostate cancer (2021) (1)
- The prognostic biomarkers of the patients treated with platinum-based chemotherapy in treatment emergent or related neuroendocrine prostate cancer. (2020) (1)
- A long-term survivor of metastatic neuroendocrine prostate cancer treated with multimodal therapy: genetic consideration from next-generation sequencing (2021) (1)
- Frequent azoospermia in patients with testicular germ cell cancer and a history of cryptorchidism: a report of nine cases and review of the literature (2021) (1)
- Difficulty in differential diagnosis for renal cancer with microscopic papillary architecture: overlapped pathological features among papillary renal cell carcinoma (RCC), mutinous tubular and spindle cell carcinoma, and unclassified RCC. Lessons from a Japanese multicenter study. (2020) (1)
- Complete response to ethnylestradiol prolonged for almost two years in patients with castration-resistant prostate cancer. (2014) (1)
- Successful perinatal management of a dichorionic diamniotic twin pregnancy in an anaemic kidney transplant patient treated with Darbepoetin alfa: a case report (2020) (1)
- New year's greetings: International Journal of Urology enters its third decade (2014) (1)
- Interstitial pneumonitis in a castration-resistant prostate cancer patient receiving cabazitaxel after thoracic radiation therapy: a case report (2019) (1)
- Effectiveness and safety of sorafenib for renal cell, hepatocellular and thyroid carcinoma: pooled analysis in patients with renal impairment (2022) (1)
- Randomized phase III trial of avelumab + axitinib vs sunitinib as first-line treatment for advanced renal cell carcinoma: JAVELIN renal 101 Japanese subgroup analysis (2019) (1)
- Planar scintigraphy does not always detect migrated seeds after transperineal interstitial permanent prostate brachytherapy with 125I radioactive seeds (2010) (1)
- On-treatment C-reactive protein control could predict response to subsequent anti-PD-1 treatment in metastatic renal cell carcinoma (2021) (1)
- 1318 HYPOXIC MICROENVIRONMENT PROMOTES PI3K/AKT/MTOR SIGNALING PATHWAYS IN HUMAN CASTRATION RESISTANT PROSTATE CANCER (2013) (1)
- Long-term efficacy and safety of iron-based phosphate binders, ferric citrate hydrate and sucroferric oxyhydroxide, in hemodialysis patients (2021) (1)
- Vasohibin-1 expression as a biomarker of aggressive nature in ductal adenocarcinoma of the prostate: a retrospective cohort study at two centres in Japan (2021) (1)
- [Biomarkers of response to molecular targeted therapy in renal cell carcinoma]. (2011) (1)
- Predictors of Survival in Favorable Risk Patients with Metastatic Renal Cell Carcinoma Treated with a Single-Agent First-Line Therapy (2022) (1)
- Bullous pemphigoid in patients receiving peritoneal dialysis: a case series and a literature survey (2021) (1)
- 2197 BONE SCAN IN PATIENTS WITH NEWLY DIAGNOSED PROSTATE CANCER; TO PERFORM OR NOT?: EXTERNAL VALIDATION OF THE CURRENTLY AVAILABLE GUIDELINES FOR JAPANESE PATIENTS (2013) (1)
- A first Japanese case of BRCA2 and RB1 co-loss organ-confined prostate cancer successfully treated by radical prostatectomy (2021) (1)
- Neutrophil-to-lymphocyte ratio is a useful biomarker for predicting worse clinical outcome in chemo-resistant urothelial carcinoma patients treated with pembrolizumab (2019) (1)
- Expression level of dihydropyrimidine dehydrogenase is associated with clinical outcome in patients with T1G3 bladder cancer treated with Bacillus Calmette-Guerin (2014) (1)
- A case of perforated appendicitis during temsirolimus treatment for metastatic renal cell carcinoma (2013) (1)
- Lenvatinib plus pembrolizumab versus sunitinib for advanced renal cell carcinoma: Japanese patients from the CLEAR study (2022) (1)
- Outcomes of sorafenib treatment of advanced renal cell carcinoma according to International Metastatic Renal Cell Carcinoma Data Consortium risk criteria: analysis of Japanese real-world data from postmarketing all-patient surveillance of sorafenib. (2022) (1)
- PROGNOSTIC SIGNIFICANCE OF ERYTHROCYTE PROTEIN BAND 4.1‐LIKE5 EXPRESSION IN UPPER URINARY TRACT UROTHELIAL CARCINOMA: MP71‐20 (2017) (0)
- 163 IMMUNOHISTOCHEMISTRY FOR CYP11B2 REVEALED SUBCAPSULAR CELL CLUSTERS WHICH AUTONOMOUSLY PRODUCE ALDOSTERONE IN HUMAN ADRENAL CORTEX (2011) (0)
- Diagnosis of acute bacterial prostatitis (2012) (0)
- [Genetic backgrounds of renal cell carcinoma]. (2006) (0)
- 649 COLOR DOPPLER SONOGRAPHIC EVALUATION OF URETERIC JET ANGLE IN DETECTING HIGH GRADE VESICOURETERAL REFLUX IN INFANTS AND YOUNG CHILDREN (2013) (0)
- 958 CAN ANTIANDROGEN WITHDRAWAL THERAPY BE PERFORMED SAFELY FOR AGGRESSIVE PROSTATE CANCER (2013) (0)
- Light-sheet microscopy: Diagnosing intratumoral heterogeneity of intact tumors in three-dimension (2018) (0)
- 784 SYNERGISTIC THERAPEUTIC EFFECT OF NF-κB AND AP-1 FUNCTION INHIBITORS ON SUPPRESSION OF CELL GROWTH AGAINST HIGHLY AGGRESSIVE BLADDER CANCER CELLS (2010) (0)
- MP27-05 ARE CALCULATED FORMULAS FOR ESTIMATING RENAL FUNCTION ADEQUATE FOR ADMINISTERED CISPLATIN-BASED CHEMOTHERAPY IN SOLITARY RENAL PATIENTS AFTER NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA? (2016) (0)
- Correction to: Castration-resistant prostate cancer patients who had poor response on first androgen deprivation therapy would obtain certain clinical benefit from early docetaxel administration (2019) (0)
- 240 PREDICTING PROSTATE SPECIFIC ANTIGEN RECURRENCE AFTER RADICAL PROSTATECTOMY BY CLINICOPATHOLOGICAL FACTORS: SUITABILITY OF MAGNETIC RESONANCE IMAGING (2013) (0)
- MP03-05 IMAGING MASS SPECTROMETRY REVEALS CO-ACCUMULATION OF ALDOSTERONE AND 18-OXOCORTISOL WITH CYP11B2 IN PRE-ADENOMATOUS STATES OF PRIMARY ALDOSTERONISM (2018) (0)
- MP16-01 OVERCOMING CABAZITAXEL RESISTANCE BY G2/M REGULATING GENES IN CASTRATION-RESISTANT PROSTATE CANCER (2020) (0)
- The comprehensive analysis of relationship between gut microbiome and treatment outcome of androgen deprivation therapy (ADT)-based treatment in patients with metastatic castration-sensitive and -resistant prostate cancer. (2023) (0)
- What do we need for eradicating kidney cancer cells? (2012) (0)
- MP26-17 COULD A HISTORY OF NON-MUSCLE INVASIVE BLADDER CANCER HAVE A PROGNOSTIC ROLE IN CT2-4AN0M0 BLADDER CANCER PATIENTS TREATED WITH RADICAL CYSTECTOMY AND NEOADJUVANT CHEMOTHERAPY? (2019) (0)
- 1019 THERAPEUTIC EFFECT AFTER TRANSUMBILICAL LAPAROSCOPIC SINGLE-SITE ADRENALECTOMY IN PATIENTS WITH PRIMARY ALDOSTERONISM: A MATCHED CASE-CONTROL STUDY (2012) (0)
- Dose adjustment of axitinib based on AUC monitoring in sunitinib-refractory advanced renal cell carcinoma. (2014) (0)
- Timing of 1st recurrence affects subsequent clinical outcome in 1st recurrent low grade Ta bladder cancer (2015) (0)
- BIOINFORMATIC ANALYSIS IDENTIFIED CANDIDATE DRUGS FOR ANDROGEN SIGNALING THROUGH MODULATING ANDROGEN RECEPTOR AND ITS SPLICE VARIANTS: MP64‐06 (2018) (0)
- Issue Information (2023) (0)
- THERAPEUTIC TARGETING OF TRANSCRIPTIONAL REPRESSOR BCL‐6 IN ENZALUTAMIDE‐RESISTANT CASTRATION‐RESISTANT PROSTATE CANCER: MP87‐20 (2017) (0)
- Potential therapeutic effects of adjuvant chemotherapy after neoadjuvant chemotherapy for locally advanced muscle-invasive bladder cancer. (2022) (0)
- MP08-04 PURIFIED PROTEIN DERIVATIVE SKIN TEST PRIOR TO BACILLUS CALMETTE-GUÉRIN THERAPY ENHANCES THE CLINICAL EFFICACY OF BCG THERAPY IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER (2018) (0)
- [What is the impact of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma?]. (2002) (0)
- MP81-06 OVERCOMING CABAZITAXEL RESISTANCE BY G2/M REGULATING GENES IN CASTRATION-RESISTANT PROSTATE CANCER (2019) (0)
- LONG-TERM OUTCOME OF RECURRENCE IN PATIENTS WITH SUPERFICIAL BLADDER CANCER: BCG INSTILLATION IS NOT SUFFICIENTLY EFFECTIVE FOR LOW RISK PATIENTS (2008) (0)
- Intravesical BCG instillation is strongly associated with a decreased risk of upper tract urothelial carcinoma recurrence as well as intravesical recurrence in elderly male patients with non-muscle invasive bladder cancer (2020) (0)
- Transient hypercalcemia in a patient with SAPHO syndrome (2021) (0)
- Dehydroxymethylepoxyquinomicin, a novel nuclear factor-κB inhibitor, prevents the development of cyclosporine A nephrotoxicity in a rat model (2020) (0)
- SIU Newsletter - March 2018 (2018) (0)
- MP13-04 DO ALL CASES OF MAGNETIC RESONANCE IMAGING NEGATIVE HAVE GOOD PROGNOSIS? (2020) (0)
- EFFECTS OF SEX HORMONES ON CELL PROLIFERATION IN HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS: MP81‐18 (2017) (0)
- MP37-15 LONG-TERM FOLLOW-UP COMPARING SALVAGE RADIATION THERAPY AND ANDROGEN DEPRIVATION THERAPY FOR BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY (2020) (0)
- Expression level of dihydropyrimidine dehydrogenase is associated with clinical outcome in patients with T1G3 bladder cancer treated with Bacillus Calmette-Guerin (2014) (0)
- 100 PREDICTIVE VALUES FOR NEPHRECTOMY AGAINST BLUNT RENAL TRAUMA: SINGLE INSTITUTE ANALYSIS OF 182 JAPANESE PATIENTS (2012) (0)
- PROGRAMMED CELL DEATH‐1 EXPRESSION IN BCG RELAPSING TUMORS IS SIGNIFICANTLY ASSOCIATED WITH STAGE PROGRESSION IN NON‐MUSCLE INVASIVE BLADDER CANCER PATIENTS: MP98‐01 (2017) (0)
- 1373 THE NOVEL NF-κB ACTIVATION INHIBITORDEHYDROXYMETHYL-EPOXYQUINOMICIN SUPPRESSES NON-IMMUNE AND IMMUNE INFLAMMATORY KIDNEY DISEASE IN RATS (2011) (0)
- 1787 DIHYDROPYRIMIDINE DEHYDROGENASE IS ASSOCIATED WITH CLINICAL OUTCOME IN T1G3 BLADDER CANCER PATIENTS TREATED WITH BACILLUS CALMETTE-GUERIN (2013) (0)
- PD13-12 EXTERNAL VALIDATION OF PROGNOSTIC IMPACT OF PATIENT AGE AND GENDER IN PATIENTS TREATED WITH RADICAL NEPHROURETERECTOMY: PROPOSED NEW PERSPECTIVE OF GENDER-ADJUSTED AGE IN UPPER TRACT UROTHELIAL CARCINOMA (2016) (0)
- Evaluation of prognostic factors and treatment options for renal angiosarcoma: A retrospective analysis of 113 reported cases. (2022) (0)
- IJU this issue (2015) (0)
- IJU this issue (2018) (0)
- USEFULNESS OF INFLAMMATORY MARKER DYNAMICS ONE MONTH AFTER THE FIRST‐LINE TARGETED THERAPY INITIATION FOR PFS PREDICTION IN PATIENTS WITH METASTATIC CLEAR CELL RENAL CELL CARCINOMA: MP16‐07 (2017) (0)
- MP63-08 CD44 VARIANT 9 EXPRESSION IS A NOVEL INDICATOR FOR IDENTIFYING POOR SURVIVAL IN PATIENTS WITH INVASIVE UROTHELIAL CARCINOMA (2019) (0)
- MP50-08 SIMULATING THE SURVEILLANCE DURATION OF INTRAVESICAL RECURRENCE AFTER RADICAL NEPHROURETERECTOMY: AN INDIVIDUALIZED RISK BASED APPROACH APPLYING THE WEIBULL MODEL (2019) (0)
- [Molecular targeting drug of kinase inhibitors for castration resistant prostate cancer]. (2014) (0)
- MR BLOCKADE IN RENAL CELL CARCINOMA REVEALED TUMOR SUPPRESSION THROUGH ENDOPLASMIC RETICULUM STRESS-INDUCED APOPTOSIS (2009) (0)
- 963 HOW DOES 5α-REDUCTASE ACTIVITY CHANGE DURING THE PROGRESSION OF CASTRATION RESISTANT PROSTATE CANCER? (2012) (0)
- MP32-11 ERECTILE FUNCTION IS HIGHLY ASSOCIATED WITH PROSTATE-SPECIFIC ANTIGEN BOUNCE IN LOCALIZED PROSTATE CANCER PATIENTS TREATED WITH PERMANENT PROSTATE BRACHYTHERAPY (2014) (0)
- Is the occurrence of higher adverse effects associated with better oncological outcome in metastatic urothelial carcinoma patients treated with pembrolizumab? (2019) (0)
- [Renal cell carcinoma]. (2010) (0)
- Radiolucent circular line in pelvis on plain x-rays. (2013) (0)
- ANDROGEN RECEPTOR ACTIVITY MODULATES RADIOSENSITIVITY IN BLADDER CANCER CELLS: MP88‐07 (2017) (0)
- Issue Information (2022) (0)
- 959 Visceral obesity is associated with better recurrence-free survival after surgeries for localized clear cell renal cell carcinoma (2013) (0)
- Castration-resistant prostate cancer patient presenting with whole genome doubling with CDK-12 mutation (2022) (0)
- PD17-03 “TUMOR BUDDING”, A NOVEL PROGNOSTIC INDICATOR FOR PREDICTING STAGE PROGRESSION IN T1 BLADDER TUMORS (2015) (0)
- 813 Impact of an adjuvant chemotherapeutic regimen on the clinical outcome in high-risk patients with upper tract urothelial carcinoma (2016) (0)
- Characterizing cyclin-dependent kinase 12(CDK12)-altered aggressive prostate cancer: a twelve-case series (2022) (0)
- Retroperitoneal mixed-type perinephric liposarcoma: A case report (2010) (0)
- Use of PSA percent tumor dimensional markers to predict biochemical recurrence after radical prostatectomy in clinically localized prostate cancer. (2011) (0)
- PD17-08 REFRAINING FROM SMOKING FOR 15 YEARS OR MORE REDUCED THE RISK OF TUMOR RECURRENCE IN NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS (2015) (0)
- Comparative study of prophylactic tadalafil or tamsulosin in patients treated wth low dose rate brachytherapy for prostate cancer (2019) (0)
- 980 VITAMIN E DERIVATIVES IN COMBINATION WITH ANTICANCER DRUGS FOR BLADDER CANCER CELLS: NF-κB IS A KEY MOLECULE FOR THE SYNERGISTIC EFFECTS OF α-TOCOPHEROL SUCCINATE AND PACLITAXEL (2010) (0)
- Exacerbation of diabetic nephropathy mimicking thrombotic microangiopathy during sunitinib treatment for metastatic renal cell carcinoma (2012) (0)
- A novel risk-based approach simulating oncologic surveillance according to smoking status after radical nephroureterectomy with upper tract urothelial carcinoma (2019) (0)
- MP21-11 UP-REGULATED NFκB ACTIVATION IS A POTENT THERAPEUTIC TARGET IN ACQUIRED PLATINUM-RESISTANT BLADDER CANCER: THE EFFICACY OF NFκB BLOCKADE BY DEHYDROXYMETHYL DERIVATIVE OF EPOXYQUINOMICIN (DHMEQ) (2014) (0)
- MP28-04 AXL IS A NOVEL PROGNOSTIC MARKER IN UPPER URINARY TRACT UROTHELIAL CARCINOM (2014) (0)
- MP83-10 CD44V8-10 INVOLVES ACQUISITION OF CISPLATIN-RESISTANCE IN UROTHELIAL CANCER (2016) (0)
- In silico screening for identification of novel drugs for reprogramming of lineage plasticity in neuroendocrine prostate cancer (2020) (0)
- Patients with metastatic renal cell carcinoma who benefit from axitinib dose titration: analysis from a randomised, double-blind phase II study (2019) (0)
- MP56-12 TIMING OF 1ST RECURRENCE AFFECTS SUBSEQUENT CLINICAL OUTCOME IN 1ST RECURRENT LOW GRADE TA BLADDER CANCER. (2014) (0)
- [Biomarker for molecular targeting therapy against renal cell carcinoma]. (2012) (0)
- LOSS OF FORKHEAD BOX PROTEIN O1 (FOXO1) IN BLADDER CANCER INDUCES TUMOR PROGRESSION AS WELL AS CHEMORESISTANCE: MP48‐13 (2017) (0)
- [CLINICAL BACKGROUND ANALYSIS ABOUT TRANSURETHRAL ELECTROCOAGULATION]. (2015) (0)
- Predictors of renal dysfunction during everolimus treatment in patients with metastatic renal cell carcinoma. (2015) (0)
- MP13-01 PREOPERATIVE NEUTROPHIL-TO-LYMPHOCYTE RATIO IS A USEFUL BIOMARKER FOR PREDICTING WORSE CLINICAL OUTCOME IN NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS WITH A PREVIOUS HISTORY OF SMOKING. (2016) (0)
- An analysis of low miR-199a expression in renal cell carcinoma (RCC) and and its association with regulation of GSK-3beta. (2011) (0)
- [mTOR inhibitors]. (2010) (0)
- Variant isoforms of CD44 expression as predictive markers for mortality in surgically treated patients with locally advanced upper tract urothelial carcinoma. (2016) (0)
- PD18-10 OPTIMAL SUBCLASSIFICATION SYSTEM FOR INTERMEDIATE-RISK NON-MUSCLE INVASIVE BLADDER CANCER (2019) (0)
- MP27-18 IMPACT OF MAXIMUM TUMOR DIAMETER ADJUSTED BY PRIMARY TUMOR LOCATION IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA MANAGED BY RADICAL NEPHROURETERECTOMY: THE MULTI-INSTITUTIONAL STUDY (2016) (0)
- 902 Prognostic significance of Snail expression in upper tract urothelial cancer and the biological role for tumor cell invasion (2012) (0)
- 593 A prospective study of the effect of 5-alpha-reductase inhibitor (dutasteride) treatment on serum free testosterone level and aging male symptoms in Japanese patients with benign prostatic hyperplasia (2012) (0)
- METABOLIC SHIFT UNDER HYPOXIC ENVIRONMENT CAUSES RESISTANCE TO MTOR INHIBITOR IN HUMAN CASTRATION RESISTANT PROSTATE CANCER (2014) (0)
- ESTROGEN RECEPTOR (ER)‐&bgr; SIGNALS INDUCE UROTHELIAL TUMORIGENESIS VIA DOWN‐REGULATION OF A POTENTIAL TUMOR SUPPRESSOR FORKHEAD BOX PROTEIN O1 (FOXO1): MP88‐08 (2017) (0)
- EFFICACY OF CHEMOTHERAPY ADMINISTRATION IN ELDERLY PATIENTS WITH METASTATIC UPPER TRACT UROTHELIAL CARCINOMA AFTER RADICAL NEPHROURETERECTOMY.: MP71‐13 (2017) (0)
- Multiple metastases of androgen indifferent prostate cancer in the urinary tract: two case reports and a literature review (2022) (0)
- 664 PROGNOSTIC SIGNIFICANCE OF 5-FLUOROURACIL METABOLISM-RELATING ENZYMES IN PATIENTS WITH UPPER URINARY TRACT UROTHELIAL CARCINOMA (2011) (0)
- Lymphoceles post radical prostatectomy (2013) (0)
- 672 UNDETECTABLE TUMOR THROUGH PREOPERATIVE MRI PREDICTS ORGAN CONFINED DISEASE AND LOWER TUMOR VOLUME IN PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER (2013) (0)
- Issue Information (2023) (0)
- Issue Information (2023) (0)
- Pyometra in a hemodialysis patient with severe constipation (2020) (0)
- Predictors of first line systemic therapy for metastatic renal cell carcinoma in IMDC favorable risk patients. (2020) (0)
- MP41-14 TYPE OF PATIENTS IN WHOM BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY CAN BE OBSERVED WITHOUT SALVAGE THERAPY (2019) (0)
- 50 THE VISCERAL TYPE OF ADIPOSE ACCUMULATION PREDICTS POTENTIAL TECHNICAL DIFFICULTIES WHEN PERFORMING LAPAROSCOPIC ADRENALECTOMY (2012) (0)
- [Stem cell biology in prostate cancer]. (2016) (0)
- New targeted agents for advanced renal cell carcinoma (2013) (0)
- IJU this issue (2013) (0)
- Strategy for PSA progression in patients undergoing salvage radiation for biochemical recurrence after radical prostatectomy (2023) (0)
- 903PThe efficacy and safety of sorafenib in patients with renal insufficiency of advanced renal cell carcinoma: Real- world data of sorafenib in Japan (2017) (0)
- Long-term outcomes of children with Xp11.2 translocation renal cell carcinoma. (2012) (0)
- MP50-06 COULD LAPAROSCOPIC SURGERY HAVE SAME LONG-TERM ONCOLOGICAL OUTCOMES AS OPEN RADICAL NEPHROURETERECTOMY IN T3N0M0 UPPER TRACT UROTHELIAL CARCINOMA? A MULTICENTER COHORT STUDY ADJUSTED BY PROPENSITY SCORE MATCHING (2019) (0)
- MP2-14 SIMULTANEOUS PRESENCE OF BLADDER CANCER AND PREVIOUS HISTORY OF BLADDER CANCER HAVE DIFFERENT IMPACTS ON CLINICAL OUTCOME OF UPPER TRACT UROTHELIAL CARCINOMA FOLLOWING RADICAL NEPHROURETERECTOMY (2015) (0)
- 763 Clinical impact of the dose modification of second-line targeted therapy for patients with metastatic renal cell carcinoma (2016) (0)
- 356: Differential Expression of Hypoxia Inducible Factor-α Subtypes in Renal Cell Carcinoma: Its Correlation with von Hippel Lindau Gene Mutation and Impact on Vascular Endothelial Growth Factor Expression (2005) (0)
- OVERCOMING PI3K/MTOR INHIBITOR RESISTANCE BY PIM1 INHIBITOR THROUGH REGULATION OF TYROSINE KINASE EXPRESSION.: MP83‐02 (2017) (0)
- 1047 Visceral obesity is a useful predictor of better recurrence-free survival after curative surgeries for Japanese patients with localized clear cell renal cell carcinoma (2014) (0)
- 1781 IS IT NECESSARY TO ROUTINELY PERFORM MULTIPLE BIOPSIES FROM NORMAL-APPEARING UROTHELIUM WHEN URINE CYTOLOGY IS POSITIVE IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER? (2013) (0)
- NUCLEAR EXPRESSION OF ARYL HYDROCARBON RECEPTOR PREDICTS DISEASE SPECIFIC SURVIVAL OF UROTHELIAL CARCINOMA OF THE UPPER URINARY TRACT (2008) (0)
- A first case of ductal adenocarcinoma of the prostate having characteristics of neuroendocrine phenotype with PTEN, RB1 and TP53 alterations (2021) (0)
- MP05-06 ESTABLISHMENT OF THE OPTIMAL FOLLOW-UP SCHEDULE AFTER RADICAL PROSTATECTOMY (2018) (0)
- Prognostic role of programmed cell death protein 1 expression in surgically treated patients with upper tract urothelial carcinoma. (2016) (0)
- Constitutive activation of mTOR pathways in renal cell carcinoma arising in dialyzed patients. (2018) (0)
- MP43-13 HIGH GAMMA-GLOBULIN LEVEL IS ASSOCIATED WITH ONCOLOGICAL OUTCOMES IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER (2019) (0)
- Impact of precise quantitative assessment of visceral obesity on outcomes of patients with metastatic renal cell carcinoma treated with systemic therapy. (2016) (0)
- A COMBINATION OF S-1 AND DOCETAXEL ACTS SYNERGISTICALLY BY MODULATING METABOLIC ENZYME AND NUCLEAR FACTOR-KAPPA B ACTIVITY IN A HUMAN PROSTATE CANCER CELL LINE (2009) (0)
- Predictors for metastatic renal cell carcinoma in IMDC favorable risk group treated with a single agent first line systemic therapy. (2022) (0)
- CHANGE OF URINARY STEROID METABOLITES IN BPH PATIENTS TREATED WITH DUTASTERIDE: MP09‐18 (2017) (0)
- MP13-17 CHARACTERIZING INTERMEDIATE-RISK NON-MUSCLE INVASIVE BLADDER CANCER: IMPLICATIONS FOR THE DEFINITION OF INTERMEDIATE RISK AND TREATMENT STRATEGY (2016) (0)
- Role of metastasectomy in patients with metastatic renal cell carcinoma (2017) (0)
- MP18-12 ONCOLOGIC SURVEILLANCE AFTER RADICAL NEPHROURETERECTOMY IN UPPER TRACT UROTHELIAL CARCINOMA PATIENTS: A NOVEL RISK-BASED APPROACH (2018) (0)
- New year's greetings (2015) (0)
- [History and current review of basic research for prostate cancer]. (2011) (0)
- Association between expression of programmed cell death-1 and smoking status in patients with upper tract urothelial carcinoma treated by radical nephroureterectomy. (2018) (0)
- Urethroplasty for hypospadias (2012) (0)
- Laparoscopy Assisted Orchiopexy : Technical Feasibility and Indications (1995) (0)
- NUCLEAR FACTOR (NF)‐&kgr;B SIGNALS PROMOTE UROTHELIAL TUMORIGENESIS THROUGH THE ANDROGEN RECEPTOR (AR) PATHWAY: MP88‐06 (2017) (0)
- WS1-1-5 Reduced Acetylation of Histone h3 in Renal Cell Carcinoma : a Potential Target of Histone Deacetylase Inhibitors(Renal Cell Cancer) (2008) (0)
- 452 Relationship between radiation doses and development of erectile dysfunction in patients treated with permanent prostate brachytherapy for localized prostate cancer (2018) (0)
- Prostate Brachytherapy Seed Migration To The Ischial Bone: 2 Case Reports (2009) (0)
- AN ASSESSMENT OF THE MOST SIGNIFICANT DETERMINANTS OF THE NATURAL HISTORY OF UPPER TRACT TRANSITIONAL CELL CARCINOMA AFTER NEPHROURETERECTOMY: A MULTI-INSTITUTIONAL RECURSIVE PARTITIONING MODEL (2009) (0)
- The efficacy of enzalutamide in castration resistant prostate cancer (2015) (0)
- Biomarkers in renal cell carcinoma: Role in clinical practice (2012) (0)
- ENHANCED CHEMOSENSITIVITY TO PACLITAXEL BY VITAMIN E SUCCINATE IN BLADDER CANCER (2008) (0)
- Novel adrenocortical histology and pathology discovered by immunohistochemistry of aldosterone synthase (2015) (0)
- MP78-15 CAN UROLOGISTS INTRODUCE THE CONCEPT OF “OLIGOMETASTASIS” FOR METASTATIC BLADDER CANCER AFTER RADICAL CYSTECTOMY? (2018) (0)
- Multicenter phase II clinical trial of everolimus in Japanese patients with unresectable or metastatic renal cell carcinoma (mRCC) after failure of treatment with first-line tyrosine kinase inhibitor (TKI) therapy. (2014) (0)
- MP05-20 IMPACT OF TUMOR LOCATION ON BIOCHEMICAL RECURRENCE AFTER LAPAROSCOPIC RADICAL PROSTATECTOMY (2018) (0)
- 969 PI3K/AKT DUAL INHIBITOR RESTORES DOCETAXEL SENSITIVITY IN CASTRATION RESISTANT PROSTATE CANCER (2012) (0)
- HEPARANASE EXPRESSION IN RENAL CELL CARCINOMAS AND ITS ASSOCIATION WITH TUMOR INVASION (2008) (0)
- [Continuation of Axitinib for Advanced Renal Cell Carcinoma by The Application of Homecare Urology - A Case Report and Literature Review]. (2018) (0)
- Discovery dichlorodiammineplatinum Upregulates Angiotensin II e 1 Receptors through Reactive Oxygen Species eration and Enhances VEGF Production Ther ladder Cancer (2010) (0)
- PD18-04 ARE SURVIVAL OUTCOMES AFTER NEOADJUVANT CHEMOTHERAPY SUPERIOR TO THOSE AFTER UPFRONT RADICAL NEPHROURETERECTOMY FOR NODE-POSITIVE UPPER TRACT UROTHELIAL CARCINOMA? RESULTS OF A MULTI-CENTER COHORT STUDY (2020) (0)
- MP56-04 IMPACT OF LYMPHOVASCULAR INVASION STATUS IN TRANSURETHRAL RESECTION OF BLADDER TUMORS COULD PREDICT SUBSEQUENT STAGE PROGRESSION IN T1 BLADDER TUMORS. (2014) (0)
- Iliopsoas abscess in patients receiving hemodialysis: a case series and a literature survey (2022) (0)
- Correction to: Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma (2021) (0)
- Current clinical perspective of urological oncology in the adolescent and young adult generation (2022) (0)
- MP77-19 THE PREDICTIVE VALUE OF C-REACTIVE PROTEIN FOR PROGNOSIS IN PATIENTS WITH METASTATIC UPPER TRACT UROTHELIAL CARCINOMA TREATED WITH CISPLATIN-BASED CHEMOTHERAPY FOLLOWING RADICAL NEPHROURETERECTOMY: MULTI-INSTITUTIONAL STUDY (2014) (0)
- [Prostate cancer stem cell and drug resistance]. (2016) (0)
- Issue Information (2019) (0)
- ANTITUMOR EFFECT OF INTERLEUKIN-2 AGAINST RENAL CELL CARCINOMA (1993) (0)
- [Enucleation performed to treat renal cell carcinoma associated with chronic nephritis: a case report]. (1991) (0)
- Locally advanced prostate cancer effected by the tumor immunoenvironment (2020) (0)
- A Case of Solitary Contralateral Adrenal Metastasis of Renal Cell Carcinoma (1999) (0)
- MP76-03 KIDNEY GRAFT DAMAGE AFTER LONG COLD ISCHEMIA TIME IS ATTENUATED BY RECOMBINANT THROMBOMODULIN ALPHA IN A RAT KIDNEY TRANSPLANT MODEL (2019) (0)
- S&T-06 HIGH ABSOLUTE MONOCYTE COUNT PREDICTS POOR CLINICAL OUTCOME IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER TREATED WITH DOCETAXEL CHEMOTHERAPY (2016) (0)
- Bladder metastasis from renal cell carcinoma: retrospective analysis of 65 reported cases (2015) (0)
- IJU this issue (2017) (0)
- EVALUATION OF PREBIOPSY MAGNETIC RESONANCE IMAGING COMBINED WITH PROSTATE‐SPECIFIC ANTIGEN DENSITY IN THE DIAGNOSIS OF PROSTATE CANCER IN MEN AGED 75 YEARS AND OLDER WITH ELEVATED PSA: PD40‐09 (2017) (0)
- IJU this issue (2018) (0)
- 787 CIS-DICHLORODIAMMINEPLATINUM UPREGULATES ANGIOTENSIN TYPE 1 RECEPTOR AND ENHANCES THE EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH FACTOR INDUCED BY ANGIOTENSIN II (2010) (0)
- 1061 ACTIVATION OF THE ARYL HYDROCARBON RECEPTOR PATHWAY ENHANCES CANCER CELL INVASION BY UP-REGULATING THE MMP EXPRESSION IN UROTHELIAL CANCER (2011) (0)
- Suitable patients for single-port laparoscopic adrenalectomy : optimal cut-off value for body mass index (2019) (0)
- Issue Information (2019) (0)
- 21 AUTONOMOUS ALDOSTERONE PRODUCTION IN NOVEL ADRENOCORTICAL CELL CLUSTERS OF NORMAL GLANDS AND NON-TUMOR PORTIONS OF ADENOMAS (2010) (0)
- MP39-14 METFORMIN IS A NEW THERAPEUTIC STRATEGY FOR TARGETING CD44 VARIANT IN BLADDER CANCER (2014) (0)
- 381: C-JUN Activation is Related to the Early Carcinogenesis of Renal Cell Carcinoma (2005) (0)
- MP2-08 URINARY PH IS HIGHLY ASSOCIATED WITH BLADDER RECURRENCE AFTER NEPHROURETERECTOMY FOR UPPER URINARY TRACT UROTHELIAL CARCINOMA PATIENTS WITH POSITIVE SMOKING HISTORY (2015) (0)
- 2193 PREOPERATIVE GRADING OF HYDRONEPHROSIS CAN IMPROVE THE ACCURACY OF WORSE PATHOLOGICAL PREDICTION IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA TREATED SURGICALLY (2012) (0)
- 1356 METASTIN, THE FINAL PEPTIDE OF KISS-1 GENE, PREVENTS LUNG METASTASES OF MURINE BLADDER CANCER (2011) (0)
- MP53-19 ANDROGEN DEPRIVATION THERAPY THROUGH THE PERI-RADIATION PERIOD REDUCES THE RISK OF BLADDER HEMORRHAGE IN PROSTATE CANCER PATIENTS UNDERGOING EXTERNAL BEAM RADIOTHERAPY (2020) (0)
- Role of vibrator-equipped penile constriction band in the quality of sexual life : A preliminary report (2003) (0)
- Risk classification for non-muscle invasive bladder cancer (2010) (0)
- Natural History of Renal Cell Carcinoma (2008) (0)
- Interstitial pneumonitis in a castration-resistant prostate cancer patient receiving cabazitaxel after thoracic radiation therapy: a case report (2019) (0)
- A case of renal cell carcinoma associated with renal tubulopapillary adenoma in hemodialysis patient (2003) (0)
- PD66-12 A NOVEL RISK BASED APPROACH SIMULATING ONCOLOGIC SURVEILLANCE ACCORDING TO SMOKING STATUS AFTER RADICAL NEPHROURETERECTOMY WITH UPPER TRACT UROTHELIAL CARCINOMA (2019) (0)
- Endoscopic vaporization of benign prostatic hyperplasia using a contact 980 nm diode laser under antithrombotic therapy: A prospective survey (2022) (0)
- MP49-03 RELATIONSHIP BETWEEN INCREASED EXPRESSION OF AXL-GAS6 SIGNAL CASCADE AND PROGNOSIS IN UPPER URINARY TRACT UROTHELIAL CARCINOMA. (2015) (0)
- MP50-07 THE SURVIVAL PREDICTION WITH TIME OF INTRAVESICAL RECURRENCE IN UPPER TRACT UROTHELIAL CARCINOMA (2019) (0)
- MP08-08 GENOMIC LANDSCAPE AND MOLECULAR CHARACTERIZATION OF RENAL CELL CARCINOMA IN DIALYSIS PATIENTS (2020) (0)
- ASO Author Reflections: Previous History of Non-urothelial Malignancy May Provide Predictive Information of Worse Clinical Outcome for Initially Diagnosed Non-Muscle Invasive Bladder Cancer (2021) (0)
- 517 INTRAVESICAL LIPOSOME-MEDIATED INTERLEUKIN-15 GENE THERAPY ENHANCES TUMOR-SPECIFIC CYTOTOXICITY IN ORTHOTOPIC MURINE BLADDER CANCER MODEL (2011) (0)
- 700 THE PROGNOSTIC SIGNIFICANCE OF VASOHIBIN-1 EXPRESSION IN PATIENTS WITH UPPER URINARY TRACT UROTHELIAL CARCINOMA (2013) (0)
- The change of serum C-reactive protein levels during molecular-targeted treatments could predict the response to anti-PD-1 treatment in metastatic renal cell carcinoma patients. (2020) (0)
- THERAPEUTIC TARGETING OF TRANSCRIPTIONAL REPRESSOR BCL‐6 FOR CASTRATION‐RESISTANT PROSTATE CANCER THROUGH REPRESSING ANDROGEN RECEPTOR VARIANTS.: MP64‐02 (2018) (0)
- 1052 DOES NF-KB ACTIVATION INHIBITOR, DHMEQ OVERCOME THE CHEMORESISTANCE TO CISPLATIN IN BLADDER CANCER? (2011) (0)
- 1912 CHANGES IN SERUM PROSTATE SPECIFIC ANTIGEN FOLLOWING HOLMIUM LASER ENUCLEATION OF THE PROSTATE IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (2010) (0)
- 584 THERAPEUTIC EFFECT OF INTRAVESICAL ADMINISTRATION OF A NOVEL NANOTRANSPORTER FOR PACLITAXEL IN AN ORTHOTOPIC BLADDER CANCER MODEL (2013) (0)
- Issue Information (2022) (0)
- 369: Activating P38 Stress Kinase is a Novel Target for the Treatment of Renal Cell Carcinoma (2005) (0)
- Treatment-free survival after discontinuation of immuno-checkpoint therapy, and outcome of subsequent molecular targeted therapy: Retrospective study of Japanese metastatic renal cell carcinoma patients (after I-O study). (2020) (0)
- Are there any significant impacts of patient age and prior treatment profile with docetaxel on the efficacy of cabazitaxel in patient with castration-resistant prostate cancer? (2019) (0)
- Issue Information (2022) (0)
- 1284 LOW DOSE DOCETAXEL ENHANCES THE SENSITIVITY OF S-1 IN A XENOGRAFT MODEL OF HUMAN CASTRATION RESISTANT PROSTATE CANCER (2011) (0)
- Long-term outcome of feminizing genitoplasty (2011) (0)
- ASO Author Reflections: Discussing the Oncological Feasibility of Performing Pure Laparoscopic Radical Nephroureterectomy for Upper-Tract Urothelial Carcinoma Patients: Results from a Multi-institution Collaborative Study Adjusted by Propensity Score Matching (2020) (0)
- LBA02-02 PROGNOSTIC VALUE OF PD-L1 EXPRESSION ON TUMOR-INFILTRATING IMMUNE CELLS IN RENAL CELL CARCINOMA (ARCHERY STUDY) (2020) (0)
- FUNCTIONAL ANALYSIS OF SNAIL IN BLADDER CANCER: A KEY TRANSCRIPTIONAL FACTOR OF EPITHELIAL TO MESENCHYMAL TRANSITION (EMT) (2009) (0)
- IMAGENE trial: multicenter, proof-of-concept, phase II study evaluating the efficacy and safety of combination therapy of niraparib with PD-1 inhibitor in solid cancer patients with homologous recombination repair genes mutation (2022) (0)
- New Targeted Approach to CRPC (2018) (0)
- 681 THE DISTINCT ASSOCIATION BETWEEN PRIMARY TUMOR LOCATION AND THE PATTERNS OF METASTATIC SPREAD FOLLOWING RADICAL NEPHROURETERECTOMY IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA (2013) (0)
- MP78-12 DOES NEOADJUVANT CHEMOTHERAPY WITH GEMCITABINE AND CISPLATIN IN BLADDER CANCER INCREASE THE COMPLICATIONS AT RADICAL CYSTECTOMY IN HIGH AGE PATIENTS? (2018) (0)
- MP50-15 SITE SPECIFIC DIFFERENCES IN SURVIVAL AMONG BLADDER, RENAL PELVIC, AND URETERAL UROTHELIAL CARCINOMA PATIENTS TREATED WITH RADICAL SURGERY (2019) (0)
- 1020: Simple Stratification of Survival Using Bone Scan and Serum C-Reactive Protein in Prostate Cancer Patients with Metastases (2007) (0)
- Umbilical closure using 2-octyl cyanoacrylate in transumbilical laparoscopic adrenalectomy: A randomized controlled trial. (2020) (0)
- MP12-11 A NOVEL PATHOLOGY RELATED TO SUBCAPSULAR ALDOSTERONE-PRODUCING CELL CLUSTERS CAUSES HYPERALDOSTERONISM (2016) (0)
- The clinical role of purified protein derivative skin test reaction in patients with non-muscle invasive bladder cancer treated with bacillus-Calmette Guerin. (2017) (0)
- 51 LAPAROSCOPIC ADRENALECTOMY INCLUDING LESS IN PATIENTS WITH PHEOCHROMOCYTOMA: THE EVALUATION OF PERIOPERATIVE SURGICAL RISK (2013) (0)
- MP17-11 IDENTIFICATION OF FOXO1 AS A TUMOR SUPPRESSOR MODULATED BY ANDROGEN RECEPTOR/ESTROGEN RECEPTOR-β SIGNALS: IMPLICATIONS FOR BLADDER CANCER PROMOTION AND CHEMORESISTANCE (2020) (0)
- Everolimus and tacrolimus (2010) (0)
- MP29-07 APC MUTATION CONTRIBUTES TO NEUROENDOCRINE DIFFERENTIATION AND POOR OVERALL SURVIVAL IN METASTATIC PROSTATE CANCER PATIENTS (2023) (0)
- PURIFIED PROTEIN DEPRIVATION SKIN TEST REACTION IS ASSOCIATED WITH CLINICAL OUTCOME OF PATIENTS WITH NON‐MUSCLE INVASIVE BLADDER CANCER TREATED WITH BACILLUS‐CALMETTE GUERIN: PD48‐09 (2017) (0)
- Pre-operative and post-operative estimated glomerular filtration rate in Japanese patients with urological malignancies (2018) (0)
- [Effect and adverse event of enzalutamide and abiraterone in prostate cancer]. (2015) (0)
- A PILOT CLINICAL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF DOCETAXEL WITH RIBAVIRIN IN PATIENTS WITH PROGRESSIVE CASTRATION‐RESISTANT PROSTATE CANCER TARGETING STEM‐CELL RELATED GENE NETWORK.: MP41‐11 (2017) (0)
- [Prospective survey of erectile dysfunction after external beam radiotherapy for prostate cancer]. (2011) (0)
- 1142 A PROSPECTIVE STUDY OF THE EFFECT OF 5-ALPHA-REDUCTASE INHIBITOR (DUTASTERIDE) TREATMENT ON SERUM FREE TESTOSTERONE LEVEL AND AGING MALE SYMPTOMS IN JAPANESE PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (2012) (0)
- A NOVEL NF-KB INHIBITOR, DEHYDROXYMETHYLEPOXYQUINOMICIN, SUPPRESSES THE IMMUNOSTIMULATORY FUNCTION OF HUMAN DENDRITIC CELLS: 1930 (2008) (0)
- DEVELOPMENT OF PROGNOSTIC MODELS FOR INDIVIDUAL RISK STRATIFICATION IN PATIENTS TREATED WITH RADICAL NEPHROURETERECTOMY: A NEW TOOL TO HELP WITH PATIENT SELECTION FOR ADJUVANT THERAPY (2009) (0)
- Development of modified IMDC model for metastatic renal cell carcinoma patients (2019) (0)
- The efficacy and safety in elderly patients with advanced renal cell carcinoma: Real-world use of sorafenib in Japan. (2017) (0)
- 1788 THE RELATIONSHIP BETWEEN RENIN-ANGIOTENSIN SYSTEM BLOCKADE AND TUMOR RECURRENCE IN NON-MUSCLE INVASIVE BLADDER CANCER (2013) (0)
- MP19-03 EXTERNAL VALIDATION OF THE "OPTIMAL PSA FOLLOW-UP SCHEDULE AFTER RADICAL PROSTATECTOMY" IN A NEW COHORT (2020) (0)
- Editorial Comment to Comparison of single‐ and multiple‐dose cefazolin as prophylaxis for transurethral enucleation of prostate: A multicenter, prospective, randomized controlled trial by the Japanese Research Group for Urinary Tract Infection (2020) (0)
- Transcription and protein phenotyping with 3D pathology: Light-sheet microscopy overlooks cellular malignancy of intact tumour volumes (2019) (0)
- WHO COULD BE ELIMINATED FOR RANDOM BIOPSIES AFTER BCG THERAPY IN PATIENTS WITH BLADDER CARCINOMA IN SITU?: MP15‐03 (2017) (0)
- 1782 SHOULD A FIRST RECURRENT LOW GRADE TA BLADDER CANCER BE MANAGED AS AN INTERMEDIATE-RISK GROUP TUMOR? (2013) (0)
- IJU this issue (2017) (0)
- Erythrocyte protein band 4.1-like5 expression in patients with upper urinary tract urothelial carcinoma correlates with tumor recurrence. (2014) (0)
- 1465 CONSERVATIVE THERAPY FOR BCG FAILURE NON-MUSCLE INVASIVE BLADDER CANCER: FOR WHOM SHOULD CYSTECTOMY BE CONSIDERED? (2010) (0)
- Site-specific differences in survival among upper and lower tract urothelial carcinoma patients treated with radical surgery. (2021) (0)
- 1124 PREDICTION AND CLINICAL IMPLICATION OF SEED MIGRATION AFTER BRACHYTHERAPY WITH I-125 FREE SEEDS IN PATIENTS WITH LOCALIZED PROSTATE CANCER (2012) (0)
- Change of the 5α/5β ratio of urinary steroid metabolites in benign prostatic hyperplasia patients treated with dutasteride. (2018) (0)
- Author ' s Accepted Manuscript Color Doppler Ultrasonographic Evaluation of the Ureteral Jet Angle to Detect Vesicoureteral Reflux in Children (2016) (0)
- Effect of genetic polymorphisms on outcomes following nivolumab for advanced renal cell carcinoma in the SNiP-RCC trial. (2023) (0)
- Baseline high-sensitivity C-reactive protein to predict progression-free survival in metastatic renal cell carcinoma patients treated with first-line sunitinib. (2013) (0)
- 506 INTRACRINE DYNAMICS OF CYP17A1 ACTIVITIES IN HUMAN CASTRATION RESISTANT PROSTATE CANCER (2013) (0)
- Reduced recurrence of low‐risk non‐muscle‐invasive bladder cancer is associated with low urine‐specific gravity (2020) (0)
- A NOVEL NF‐?B INHIBITOR DEHYDROXYMETHYLEPOXYQUINOMICIN PREVENTS ACUTE REJECTION OF KIDNEY ALLOGRAFTS IN A RAT MODEL: MP74‐15 (2017) (0)
- [The molecular mechanisms of resistance to androgen deprivation therapy in prostate cancer]. (2012) (0)
- LAPAROSCOPIC NEPHROURETERECTOMY DOES NOT UNDERMINE CANCER CONTROL OUTCOMES IN SELECTED PATIENTS WITH NON-METASTATIC UPPER TRACT UROTHELIAL CARCINOMA (2009) (0)
- 218 DOWN-REGULATION OF MITOGEN-ACTIVATED PROTEIN KINASE PHOSPHATASE-1 EXPRESSION PREDICTS FOR POOR SURVIVAL IN RENAL CELL CARCINOMA (2010) (0)
- The checkpoints for the diagnosis of renal neoplasms (2009) (0)
- Characteristics and prognostic factor in patients with advanced renal cell carcinoma (RCC) achieving complete response by treatment using biological response modifiers (BRM) (1996) (0)
- ELEVATED EXPRESSION OF ARYL HYDROCARBON RECEPTOR IN RENAL CELL CARCINOMA IS ASSOCIATED WITH CIGARETTE SMOKE AND THE PROGNOSIS (2009) (0)
- PD33-04 NATIONWIDE SURVEY ON PERIOPERATIVE MANAGEMENT AND SURGICAL SITE INFECTION OF PATIENTS WHO UNDERWENT TRANSVAGINAL MESH FOR TREATMENT OF PELVIC ORGAN PROLAPSE (2014) (0)
- Hybridisation chain reaction-based visualisation and screening for lncRNA profiles in clear-cell renal-cell carcinoma (2022) (0)
- The timing from perioperative chemotherapy and disease recurrence could have clinical impact on survival in bladder cancer patients treated with salvage chemotherapy. (2019) (0)
- Clinical pearls in treatment for the patients of adrenal tumor (2014) (0)
- MP24-10 DRUG EFFICACY REPROGRAMMING BY RIBAVIRIN AGAINST THE CANCER STEMNESS IN DOCETAXEL-RESISTANT PROSTATE CANCER (2014) (0)
- THE THERAPEUTIC EFFECTS OF THE HUMAN INTERLEUKIN-6 RECEPTOR ANTIBODY (TOCILIZUMAB) ON PROSTATE CANCER (2008) (0)
- THE EFFECTIVE PERIOD OF FIRST ANDROGEN DEPRIVATION THERAPY BECOMES AN PROGNOSTIC THE EFFECTIVE PERIOD OF FIRST ANDROGEN‐DEPRIVATION THERAPY BECOMES AN PROGNOSTIC FACTOR IN DOCETAXEL CHEMOTHERAPY FOR CASTRATION‐RESISTANT PROSTATE CANCER PATIENTS: MP53‐06 (2017) (0)
- Transumbilical laparoendoscopic single-site varicocelectomy (2012) (0)
- Survival by Depth of Response and Efficacy by International Metastatic Renal Cell Carcinoma Database Consortium Subgroup with Lenvatinib Plus Pembrolizumab Versus Sunitinib in Advanced Renal Cell Carcinoma: Analysis of the Phase 3 Randomized CLEAR Study. (2023) (0)
- Recombinant Thrombomodulin Alpha Protects Kidney Graft from Damage after Long Cold Ischemia Time in a Rat Kidney Transplant Model (2018) (0)
- MP72-13 PERFORMING TRANSURETHRAL RESECTION UNDER GENERAL ANESTHESIA MAY CONTRIBUTE TO HIGHER RECURRENCE RATES IN HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER (2020) (0)
- Squamous cell carcinoma of the prostate with SMARCA4 alteration in a Japanese patient (2022) (0)
- 461 PREDICTION AND STRATIFICATION OF ALPHA-BLOCKER DEPENDENCY FOLLOWING BRACHYTHERAPY IN PATIENTS WITH LOCALIZED PROSTATE CANCER (2010) (0)
- 1069 CLINICAL SIGNIFICANCE OF SNAIL EXPRESSION IN BLADDER TUMOR AND ITS HYPOXIC REGULATION (2011) (0)
- 670 PROGNOSTIC SIGNIFICANCE OF NUCLEAR EXPRESSION OF ARYL HYDROCARBON RECEPTOR IN UROTHELIAL CARCINOMA OF THE UPPER URINARY TRACT (2009) (0)
- Laparoscopic vesical diverticulectomy (2018) (0)
- MP36-07 EVALUATING THE DIAGNOSTIC ACCURACY OF VESICAL IMAGING-REPORTING AND DATA SYSTEM FOR DETECTING MUSCLE-INVASIVE BLADDER CANCER IN REAL CLINICAL SETTING (2020) (0)
- Prognostic rule of programmed cell death protein 1 expression in resectable upper tract urothelial carcinoma. (2017) (0)
- Issue Information (2022) (0)
- 200 MTOR pathway regulates the expression of angiotensin II type 1 receptor in renal cell carcinoma (2014) (0)
- Adjuvant nivolumab versus placebo following radical surgery for high-risk muscle-invasive urothelial carcinoma: a subgroup analysis of Japanese patients enrolled in the phase 3 CheckMate 274 trial (2022) (0)
- Issue Information ‐ TOC (2016) (0)
- Lower urinary pH increases the risk of upper tract urothelial carcinoma development in patients with non-muscle invasive bladder cancer (2019) (0)
- Single-Cell Phenotyping of CD73 Expression Reveals the Diversity of the Tumor Immune Microenvironment and Reflects the Prognosis of Bladder Cancer. (2023) (0)
- Iconographies supplémentaires de l'article : Solifenacin or Mirabegron Could Improve Persistent Overactive Bladder Symptoms After Dutasteride Treatment in Patients With Benign Prostatic Hyperplasia (2015) (0)
- Visualization of aldosterone-related steroids on adrenal frozen sections (2017) (0)
- 734 ACTIVATION OF ARYL HYDROCARBON RECEPTOR PROMOTES EPITHELIAL-MESENCHYMAL TRANSITION OF RENAL CELL CARCINOMA BY INDUCING SLUG AND MATRIX METALLOPROTEINASES (2011) (0)
- Final efficacy and safety results and biomarker analysis of a phase 2 study of cabozantinib in Japanese patients with advanced renal cell carcinoma (2023) (0)
- SUPER‐SELECTIVE ADRENAL VENOUS SAMPLING IS USEFUL FOR EVALUATING CORTISOL‐PRODUCING ADENOMA: MP37‐06 (2017) (0)
- ASO Author Reflections: Could Laparoscopic Surgery Have the Same Long-Term Oncological Outcomes as Open Radical Nephroureterectomy in T3N0M0 Upper Tract Urothelial Carcinoma? A Multicenter Cohort Study Adjusted by Propensity Score Matching (2019) (0)
- PD64-03 UNCOVERING INTRA-TUMOR AXL EXPRESSION HETEROGENEITY AND OUTCOMES IN CLEAR CELL RENAL CELL CARCINOMA (2020) (0)
- 1748 ANGIOTENSIN II TYPE 1 RECEPTOR AND MICROVESSEL DENSITY PREDICT THE EARLY INTRAVESICAL RECURRENCE IN BLADDER CANCER (2011) (0)
- PREOPERATIVE NEUTROPHIL‐TO‐LYMPHOCYTE RATIO AND SMOKING HISTORY ARE INDEPENDENTLY ASSOCIATED WITH BCG RELAPSING TUMOR RECURRENCE IN NON‐MUSCLE INVASIVE BLADDER CANCER PATIENTS: PD48‐10 (2017) (0)
- Survival prediction in axitinib-treated patients with metastatic renal cell carcinoma (2017) (0)
- LYMPHOVASCULAR INVASION IS INDEPENDENTLY ASSOCIATED WITH CANCER RECURRENCE AND SURVIVAL IN PATIENTS WITH NEGATIVE LYMPH NODES AT RADICAL NEPHROURETERECTOMY (2008) (0)
- Three-dimensional conformal arc radiotherapy using a C-arm linear accelerator with a computed tomography on-rail system for prostate cancer: clinical outcomes (2015) (0)
- MP90-09 A NEW STRATEGY FOR THE TREATMENT OF PROSTATE CANCER BY TARGETING VASOHIBIN-2 (2016) (0)
- The role of programmed cell death-1 positivity in tumor nest on clinical outcome in upper tract urothelial carcinoma patients treated with radical nephroureterectomy (2017) (0)
- Negative impact of neoadjuvant hormonal therapy on detecting biochemical recurrence after radical prostatectomy (2021) (0)
- Antitumor Effect of Interleukin-2 Entrapped in Liposomes on Murine Renal Cell Carcinoma (2008) (0)
- Ductal adenocarcinoma of the prostate (2019) (0)
- MP69-06 RISK FACTORS FOR HEMODYNAMIC INSTABILITY DURING LAPAROSCOPIC ADRENALECTOMY FOR PHEOCHROMOCYTOMA. (2019) (0)
- Splenic cord capillary hemangioma with non-islet cell tumor hypoglycemia: a case report (2019) (0)
- THE INSUFFICIENT MMF CAUSED HLA ANTIBODY DEVELOPMENT IN THE LONG TERM KIDNEY TRANSPLANT.: 1370 (2010) (0)
- Salvage focal brachytherapy in castration‐resistant prostate cancer with neuroendocrine differentiation after radiation therapy (2022) (0)
- Issue Information (2009) (0)
- 973 A NEW STRATEGY FOR CASTRATION RESISTANT PROSTATE CANCER WITH TARGETING TO FEEDBACK MECHANISM OF PI3K/AKT/MTOR PATHWAY (2013) (0)
- 901 PREDICTION AND STRATIFICATION OF THE DEVELOPMENT OF URINARY RETENTION IN PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER TREATED WITH HORMONE THERAPY (2011) (0)
- IN SILICO SCREENING USING RNA‐SEQ DATA SETS OF NEUROENDOCRINE PROSTATE CANCER HAS IDENTIFIED CANDIDATE DRUGS FOR REPROGRAMMING NEPC‐SPECIFIC SIGNATURES.: MP64‐09 (2018) (0)
- Complete response with early introduction of cabazitaxel in a patient with multiple lung metastases of castration-resistant prostate cancer following the early detection of metastases using liquid biopsy: a case report (2019) (0)
- THE EFFECT OF A NOVEL NUCLEAR FACTOR K (KAPPA) B ACTIVATION INHIBITOR ON THE RENAL INFLAMMATORY RESPONSES IN RENAL ISCHEMIA REPERFUSION IN RAT: 110 (2008) (0)
- 4 Combinational epigenetic therapy targeting EZH2 and histone deacetylase in prostate cancer cells: Synergic effect on induction of apoptosis and TIMP3 tumor suppressor gene (2014) (0)
- Differential diagnosis of upper urinary tract disorders (2013) (0)
- Imaging , Diagnosis , Prognosis The Prognostic Signi fi cance of Vasohibin-1 Expression in Patients with Upper Urinary Tract Urothelial Carcinoma (2012) (0)
- Editorial comment. (2009) (0)
- MP26-01 PRETREATMENT NEUTROPHIL-TO-LYMPHOCYTE RATIO IS A NOVEL BIOMARKER FOR PREDICTING WORSE CLINICAL OUTCOME IN CHEMO-RESISTANT UROTHELIAL CARCINOMA PATIENTS TREATED WITH PEMBROLIZUMAB (2019) (0)
- Prognostic significance of 5-fluorouracil metabolism-relating enzymes and enhanced chemosensitivity to 5-fluorouracil by 5-chloro 2,4-dihydroxy-pyridine in urothelial carcinoma (2012) (0)
- 880 ACQUIRED PLATINUM RESISTANCE INDUCES ANGIOGENIC AGGRESSIVENESS THROUGH UPREGULATION OF ANGIOTENSIN II TYPE 1 RECEPTORS IN BLADDER CANCER (2012) (0)
- IJU this issue (2011) (0)
- The clinical impact of serum C-reactive protein levels in metastatic renal-cell carcinoma patients treated by second-line molecular targeted therapies. (2018) (0)
- 405: Previous History of Bladder Cancer is an Independent Prognostic Factor for Upper Tract Transitional Cell Carcinoma (2007) (0)
- Issue Information (2022) (0)
- DISCONTINUANCE OF BCG INSTILLATION THERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER HAS A NEGATIVE IMPACT ON TUMOR RECURRENCE (2009) (0)
- 364 THE CORRELATION OF CLASSIC CADHERINS WITH CLINICOPATHOLOGICAL FACTORS IN PATIENTS WITH UPPER URINARY TRACT UROTHELIAL CARCINOMA (2011) (0)
- MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer (2020) (0)
- MP49-16 WHO COULD BE EFFECTIVELY TREATED WITH ADJUVANT CHEMOTHERAPY AMONG PATHOLOGICALLY NODE POSITIVE MUSCLE INVASIVE BLADDER CANCER PATIENTS TREATED WITH RADICAL CYSTECTOMY? : A MULTICENTER COHORT STUDY ADJUSTED BY PROPENSITY SCORE MATCHING (2020) (0)
- 760: Association between Survivin Expression and Cell Proliferation in Renal Cell Carcinoma: Regulation of Survivin by Insulin-Like Growth Factor-1, Interferon-γ and a Novel NF-κB Inhibitor Dehydroxymethyl-Epoxyquinomicin (2004) (0)
- 229 HOW DOES ETS FAMILY CONTRIBUTE TO PROSTATE CANCER PROGRESSION (2010) (0)
- PS-R07-5: A CASE OF PRIMARY ALDOSTERONISM WITH DECLINED GLOMERULAR FILTRATION RATE AFTER ADRENALECTOMY (2023) (0)
- Author Correction: MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer (2020) (0)
- Lymphorrhea and lymphocele (2012) (0)
- Efficacy of systemic therapy for metastatic renal cell carcinoma in patients over 75 years of age. (2019) (0)
- 28 THE VISCERAL TYPE OF ADIPOSE ACCUMULATION PREDICTS POTENTIAL TECHNICAL DIFFICULTIES WHEN PERFORMING LAPAROENDOSCOPIC SINGLE-SITE ADRENALECTOMY (2011) (0)
- Does neoadjuvant chemotherapy affect postoperative complication rates in elderly patients treated with radical cystectomy for bladder cancer (2018) (0)
- Selection and efficacy of PDE5 inhibitors (2011) (0)
- 1059 REACTIVE OXYGEN SPECIES GENERATION INCREASED BY CIS-DICHLORODIAMMINEPLATINUM ENHANCES VEGF PRODUCTION THROUGH UPREGULATING ANGIOTENSIN II TYPE 1 RECEPTOR IN BLADDER CANCER (2011) (0)
- Combination of 5α-reductase inhibitor with combined androgen blockade (CAB) as a novel cytoreductive regimen before prostate brachytherapy: Ultra-CAB. (2015) (0)
- Issue Information (2021) (0)
- Optimal surgical treatment for paratesticular leiomyosarcoma: retrospective analysis of 217 reported cases (2022) (0)
- IMPACT OF TUMOR LOCATION ON BIOCHEMICAL RECURRENCE OF PT3 PROSTATE CANCER: PD15‐06 (2017) (0)
- 939 Up-regulated 17,20-lyase activity in human castration resistant prostate cancer (2012) (0)
- Is the occurrence of higher adverse effects associated with better oncological outcome in Japanese metastatic urothelial carcinoma patients treated with pembrolizumab? (2019) (0)
- MP03-12 SUITABLE PATIENTS FOR SINGLE-PORT LAPAROSCOPIC ADRENALECTOMY: OPTIMAL CUT-OFF VALUE OF BODY MASS INDEX (2018) (0)
- Issue Information (2021) (0)
- MP54-04 SIMPLE AND PRACTICAL NOMOGRAMS FOR PREDICTING STONE-FREE RATE AFTER EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY IN PATIENTS WITH SOLITARY STONE IN UPPER URINARY TRACT (2016) (0)
- Impact of precise quantitative assessment of baseline visceral fat accumulation on prognosis in patients with metastatic renal cell carcinoma treated with systemic therapy (2016) (0)
- ROLE OF ESTROGENS IN PATIENTS WITH HORMONE REFRACTORY PROSTATE CANCER (2009) (0)
- Guideline adherence for radical cystectomy significantly affects survival outcomes in non-muscle-invasive bladder cancer patients. (2021) (0)
- [Risk factors in localized prostate cancer]. (2016) (0)
- 919 High nuclear grade has strong prognostic significance in patients with pathologic T1a renal cell carcinoma (2012) (0)
- Avelumab Plus Axitinib as First-Line Therapy for Advanced Renal Cell Carcinoma: Long-Term Results from the JAVELIN Renal 100 Phase Ib Trial (2022) (0)
- A Japanese case of castration-resistant prostate cancer with BRCA2 and RB1 co-loss and TP53 mutation: a case report (2022) (0)
- 1265 PROGNOSTIC SIGNIFICANCE OF HIGH NUCLEAR GRADE FOR PATIENTS WITH PATHOLOGIC T1A RENAL CELL CARCINOMA (2011) (0)
- MP70-03 OPTIMAL TIMING OF HORMONAL THERAPY FOR PROSTATE-SPECIFIC ANTIGEN RECURRENCE AFTER RADICAL PROSTATECTOMY (2014) (0)
- Issue Information (2021) (0)
- IV. Current Economic Issues in Treatment for Metastatic Renal Cell Carcinoma (2019) (0)
- 697 C-REACTIVE PROTEIN INDEPENDENTLY PREDICTS THE PROGNOSIS OF PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA TREATED WITH RADICAL NEPHROURETERECTOMY: A MULTI-INSTITUTIONAL STUDY (2013) (0)
- 1109 Does laparoendoscopic single-site adrenalectomy in patients with unilateral pheochromocytoma increase surgical risk? A case control study (2012) (0)
- Tokuda Akihiro Tomida Shinya Toyokuni Hitoshi Tsuda Shoichiro Tsugane Tatsuhiko Tsunoda Heiichiro Udono Koji Ueda Yoshimasa Uehara Hiroo Ueno Kazuo Umezawa Toshikazu Ushijima Toshihiko Wakabayashi Kenji Wakai Tetsuro Watabe (2016) (0)
- Predicting the risk factors for muscle-invasive intravesical tumors that subsequently progressed from upper-tract urothelial carcinoma: Results of a multi-center cohort study (2020) (0)
- MP08-11 SWITCHING OF BACILLUS CALMETTE-GUÉRIN (BCG) STRAIN AT SECOND BCG THERAPY MAY REDUCE BCG-RELATED SIDE EFFECTS IN PATIENTS WITH BCG-RELAPSING TUMOR (2018) (0)
- Effects of baseline C-reactive protein on prognosis in patients with metastatic non-clear cell renal cell carcinoma treated with systemic therapy. (2023) (0)
- Issue Information (2022) (0)
- PS3-2 Genomic characterization of circulating tumor DNA in advanced genitourinary cancer patients SCRUM-Japan MONSTAR SCREEN (2021) (0)
- Prognostic value of serum C-reactive protein level prior to second-line treatment in intermediate risk metastatic renal cell carcinoma patients. (2019) (0)
- Hormonal therapy for localized prostate cancer in Japan: The outcome of J-CaP database. (2012) (0)
- IJU this issue (2012) (0)
- Antitumor effects of interleukin 2 against advanced renal cell carcinoma and prognosis of the patients by long term follow-up (1995) (0)
- 117 LOW MIR-199A EXPRESSION IN RENAL CELL CARCINOMA (RCC) IS RELATED TO MALIGNANT PHENOTYPE VIA UPREGULATION OF GSK-3BETA (2011) (0)
- MP59-01 NOVEL NUCLEAR FACTOR-κB ACTIVATION INHIBITOR, DEHYDROXYMETHYLEPOXYQUINOMICIN, PREVENTS THE DEVELOPMENT OF CHRONIC CYCLOSPORINE NEPHROPATHY (2020) (0)
- Influence of response to prior docetaxel on sensitivity to cabazitaxel in prostate cancer patients with PTEN alterations (2022) (0)
- MP62-07 DO ALL PATIENTS WHO HAVE PROSTATE CANCER WITH SEMINAL VESICLE INVASION HAVE POOR PROGNOSIS? (2020) (0)
- 717 What changed after mastering surgical skills in laparoendoscopic single-site adrenalectomy? (2015) (0)
- 558 FUNCTIONAL ANALYSIS OF MIRNA IN TUMOR MICROENVIRONMENT AS A KEY REGULATOR OF AGGRESSIVE ANGIOGENESIS OF HORMONE-REFRACTORY PROSTATE CANCER (2010) (0)
- IJU this issue (2016) (0)
- INTRAVESICAL INTERLEUKIN-15 GENE THERAPY IN A MOUSE ORTHOTOPIC BLADDER CANCER MODEL (2009) (0)
- Three-dimensional single-cell imaging for the analysis of RNA and protein expression in intact tumour biopsies (2020) (0)
- Urothelial carcinoma cancer cells acquires cisplatin resistance via muc1-c oncoprotein regulation (2020) (0)
- MP90-03 REACTIVE OXYGEN SPECIES INDUCTION BY CABAZITAXEL VIA INHIBITION OF THE SESTRIN FAMILY IN CASTRATION-RESISTANT PROSTATE CANCER (2016) (0)
- ROLES OF TOPOISOMERASE INHIBITORS AND CISPLATIN FOR CRPC IN THE POST‐CABAZITAXEL SETTING: MP70‐12 (2018) (0)
- Issue Information (2022) (0)
- Abstract 2071: Identification of FOXO1 as a tumor suppressor modulated by androgen receptor/estrogen receptor-βsignals: Implications for bladder cancer promotion and chemoresistance (2020) (0)
- Decision tree for the diagnosis of upper tract urothelial carcinoma: Can selective upper-tract urine cytology be omitted in diagnosis? (2015) (0)
- Imaging findings of renal angiomyolipoma with epithelial cysts: A case report (2010) (0)
- Issue Information (2022) (0)
- S13-6 Gateways to apoptosis : the role of the cytokine-dependent signal transduction pathways in renal cell carcinoma (2004) (0)
- The sialyl-Tn antigen synthase genes regulates migration–proliferation dichotomy in prostate cancer cells under hypoxia (2023) (0)
- CORRELATION BETWEEN CABAZITAXEL RESISTANCE AND EMT IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER: MP83‐10 (2017) (0)
- response from a randomized phase II study in metastatic renal cell carcinoma (2015) (0)
- Issue Information (2023) (0)
- Prognostic role of the innate immune signature CD163 and "eat me" signal calreticulin in clear cell renal cell carcinoma. (2023) (0)
- A case of primary retroperitoneal cystadenocarcinoma: A case report (2008) (0)
- Issue Information (2022) (0)
- 976 CIS-DICHLORODIAMMINEPLATINUM UPREGULATES THE EXPRESSION OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-γ AND ENHANCES THE CYTOTOXICITY OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-γ AGONIST (2010) (0)
- 556 NOVEL NF-KAPPAB INHIBITOR DHMEQ: THE NEW STRATEGY FOR ACQUIRED CHEMO-RESISTANT BLADDER CANCER (2012) (0)
- 1211 DOES LAPAROENDOSCOPIC SINGLE-SITE ADRENALECTOMY INCREASE SURGICAL RISK IN PATIENTS WITH UNILATERAL PHEOCHROMOCYTOMA?; CASE CONTROL STUDY (2011) (0)
- MP40-07 LONG-TERM FOLLOW-UP DATA AFTER RADICAL PROSTATECTOMY: DETERMINING WHEN TO STOP PSA MONITORING (2016) (0)
- Incidence and timing of inadvertent nephrostomy catheter displacement in patients with ureteral obstruction . (2018) (0)
- [Ⅳ. Current Economic Issues in Treatment for Metastatic Renal Cell Carcinoma]. (2019) (0)
- Is inflammation related to any diseases? (2013) (0)
- 968 REGULATION OF MCP-1 EXPRESSION THROUGH ANGIOTENSIN II TYPE 1 RECEPTOR IN CASTRATION-RESISTANT PROSTATE CANCER (2012) (0)
- 1951 OBSTRUCTIVE SLEEP APNEA SYNDROME SHOULD BE CONSIDERED AS ONE OF CAUSES FOR NOCTURIA IN YOUNGER PATIENTS WITHOUT OTHER VOIDING SYMPTOM (2013) (0)
- 965 LONG-TERM ANDROGEN ABLATION AND TREATMENT WITH TAXANES UP-REGULATE PHOSPHORYLATED AKT IN CASTRATION RESISTANT PROSTATE CANCER (2012) (0)
- Long-term follow-up comparing salvage radiation therapy and androgen-deprivation therapy for biochemical recurrence after radical prostatectomy (2021) (0)
- 450 What prevents lymphocele development after laparoscopic radical prostatectomy (2012) (0)
- MP03-13 CLINICAL OUTCOMES IN PATIENTS WITH METASTATIC PAPILLARY RENAL CELL CARCINOMA: A JAPANESE MULTI-INSTITUTIONAL STUDY (2016) (0)
- MP01-01 TNFAIP2: A POTENTIAL TARGET IN PLATINUM RESISTANCE UROTHELIAL CARCINOMA (2020) (0)
- Predictors of renal function after adrenalectomy in patients with Cushing or subclinical Cushing syndrome (2022) (0)
- 818 Site specific pattern of metastatic behavior in upper tract urothelial carcinoma treated with radical nephroureterectomy (2013) (0)
- MP41-07 COULD ADJUVANT CHEMOTHERAPY HAVE ADDITIONAL THERAPEUTIC BENEFIT IN BLADDER CANCER PATIENTS TREATED WITH RADICAL CYSTECTOMY AND NEOADJUVANT CHEMOTHERAPY? (2018) (0)
- An organ-derived extracellular matrix triggers in situ kidney regeneration in a preclinical model (2022) (0)
- Retrocaval Ureter Manifested after Ureteral Reimplantation for Ipsilateral Vesicoureteral Reflux: A Case Report. (2018) (0)
- MP37-05 IN SILICO SCREENING TARGETING THE REPROGRAMMING OF LINEAGE PLASTICITY IN NEUROENDOCRINE PROSTATE CANCER (2020) (0)
- Real-world use of sorafenib for advanced renal cell carcinoma patients with cardiovascular disease: Nationwide survey in Japan. (2019) (0)
- Perspective in urological oncology in Japan: current status and promising new agents (The 49th annual meeting of Japanese Society of Clinical Oncology educational book) -- (JSCO University: Urological cancers) (2011) (0)
- C-reactive protein (CRP) as a predictive marker for outcomes with avelumab + axitinib (A + Ax) in patients with poor-risk advanced renal cell carcinoma (aRCC): Exploratory analysis from JAVELIN Renal 101. (2023) (0)
- 1766 THE CLINICAL FEATURE OF WORSENING PROGRESSION IN PATIENTS WITH PTA NON-MUSCLE INVASIVE BLADDER TUMORS (2012) (0)
- Greeting from the new Editor‐in‐Chief: Providing evidence as well as contributing to academic communities (2013) (0)
- Issue Information (2021) (0)
- MP39-20 ARE THERE ANY APPROPRIATE CRITERIA FOR RECOMMENDING PROSTATE BIOPSY IN PATIENTS OVER 75 YEARS OLD? (2016) (0)
- 1107 Technical difficulties of transumbilical laparoendoscopic single-site adrenalectomy: Comparison with conventional laparoscopic adrenalectomy (2012) (0)
- Variant isoforms of CD44 involves acquisition of chemoresistance to cisplatin and has potential as a novel indicator for identifying a cisplatin-resistant population in urothelial cancer (2018) (0)
- MP21-13 THERAPEUTIC EFFECT BY TARGETING BCL-XL PROTEIN IN UROTHELIAL CARCINOMA CELLS (2014) (0)
- Issue Information (2022) (0)
- ' s response to reviews Title : Therapeutic effect of intravesical administration of paclitaxel solubilized with poly ( 2-methacryloyloxyethyl phosphorylcholine-con-butyl methacrylate ) in an orthotopic bladder cancer model (2014) (0)
- O9-1 Updated analysis of circulating tumor DNA in advanced genitourinary cancers: SCRUM-Japan MONSTAR SCREEN Project (2022) (0)
- 617P Genomic profiling of circulating tumor DNA in advanced genitourinary cancer patients: SCRUM-Japan MONSTAR SCREEN Nationwide Cancer Genome Screening Project (2021) (0)
- MP24-14 METABOLIC SHIFT UNDER HYPOXIC ENVIRONMENT CAUSES RESISTANCE TO MTOR INHIBITOR IN HUMAN CASTRATION RESISTANT PROSTATE CANCER. (2014) (0)
- Increased activation of mammalian target of rapamycin pathway in renal cell carcinoma arising in native kidneys of dialyzed patients (2018) (0)
- Does neoadjuvant chemotherapy affect postoperative complication rates in elderly patients treated with radical cystectomy for bladder cancer? (2018) (0)
- MP54-04 THE NEW DIAGNOSTIC APPROACH USING URETERAL JET ANGLE MEASUREMENT IN CHILDREN WITH URINARY TRACT INFECTION (2015) (0)
- Genomic analysis of aggressive ductal adenocarcinoma of the prostate (2022) (0)
- EXPRESSION OF BMI-1 IN RENAL CELL CARCINOMAS AND ITS ASSOCIATION WITH CANCER CELL PROLIFERATION (2009) (0)
- MP7-10 THE PROGNOSTIC IMPACT OF HISTONE H3K27 TRIMETHYLATION REGULATED BY EZH2 IN PATIENTS WITH UPPER URINARY TRACT UROTHELIAL CARCINOMA (2015) (0)
- THE IMPACT OF MODIFIED INTERNATIONAL METASTATIC RENAL CELL CARCINOMA DATABASE CONSORTIUM MODEL USING A TWO‐STEP STRATIFICATION PROCESS: MP67‐11 (2017) (0)
- Purified protein derivative skin test reactions are associated with tumor recurrence rate in patients with non-muscle invasive bladder cancer treated with bacillus-Calmette Guérin (2017) (0)
- MP08-19 A SIMPLE/RAPID RNA IMAGING TECHNIQUE QHCR REVEALS MALIGNANCY ASSOCIATED WITH LONG NON-CODING RNA IN CLEAR CELL RENAL CELL CARCINOMA (2020) (0)
- Right orbital metastasis from left renal cell carcinoma: A case report (2008) (0)
- 969 NOVEL THERAPEUTIC MODALITY OF S-1 IN COMBINATION WITH CPT-11 TO OVERCOME 5-FLUOROURACIL RESISTANCE IN BLADDER CANCER (2010) (0)
- The role of preoperative grading of hydronephrosis to predict pathologic outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma. (2011) (0)
- MP01-02 SULFASALAZINE COULD MODULATE THE CD44V9-XCT SYSTEM AND ENHANCE CDDP-INDUCED CYTOTOXIC EFFECTS IN METASTATIC BLADDER CANCER; A NOVEL THERAPEUTIC STRATEGY FOR METASTATIC BLADDER CANCER (2020) (0)
- Obstructive azoospermia caused by low ligation of varicocele: A case report (2017) (0)
- MP29-02 INCREASED EXPRESSION OF ARYL HYDROCARBON RECEPTOR IN CLEAR CELL RENAL CELL CARCINOMA AND INFILTRATING LYMPHOCYTES: IMPLICATIONS FOR CANCER INVASION, PROGNOSIS AND TUMOR IMMUNITY (2014) (0)
- A first Japanese Case of Intraductal Cancer of the Prostate with CHEK2 Mutation (2020) (0)
- ANDROGEN RECEPTOR SIGNALING REDUCES RADIOSENSITIVITY IN BLADDER CANCER: MP58‐03 (2018) (0)
- 665P Role of prior nephrectomy for synchronous metastatic renal cell carcinoma (mRCC) on efficacy in patients treated with avelumab + axitinib (A + Ax) or sunitinib (S): Results from JAVELIN Renal 101 (2021) (0)
- PD11-06 THE ROLE OF SINGLE INSTILLATION CHEMOTHERAPY IN PATIENTS WHO RECEIVE SUBSEQUENT BACILLUS CALMETTE-GUERIN FOR NON-MUSCLE INVASIVE BLADDER CANCER (2016) (0)
- Faculty Opinions recommendation of Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma. (2018) (0)
- 362: Inhibition of the Ubiquitin-Proteasome Pathway Activates Mitogen-Activated Protein Kinases and Induces Apoptosis in Renal Cancer Cells (2005) (0)
- Abstract LB-153: Prognostic value of PD-L1 expression on tumor-infiltrating immune cells in renal cell carcinoma (ARCHERY study) (2020) (0)
- Impacts of MMF Intervention in PRA-Positive Patients after Renal Transplantation: 673 (2012) (0)
- 519PCabazitaxel plus prednisolone with primary prophylaxis with pegfilgrastim (PEG) in Japanese patients with metastatic castration-resistant prostate cancer: An open label prospective phase 2 study (2017) (0)
- PD66-02 THE CLINICAL IMPACT OF INDURATION RESULTING FROM PURIFIED PROTEIN DEPRIVATION SKIN TEST IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER TREATED WITH BACILLUS-CALMETTE GUÉRIN (2018) (0)
- Retroperitoneal neurilemmoma: A case report (1991) (0)
- MP52-20 POST-TRANSLATIONAL MODIFICATION MEDIATED BY THE PROLYL ISOMERASE PIN1 ACCERELATE CANCER PROGRESSION IN CASTRATION RESISTANT PROSTATE CANCER (2014) (0)
- 386 PROGNOSTIC VALUE OF PLASMA FIBRINOGEN LEVELS IN PATIENTS WITH LOCALIZED UPPER TRACT UROTHELIAL CARCINOMA (2012) (0)
- CDK12 and HER2 coamplification in two urothelial carcinomas with rapid and aggressive clinical progression (2020) (0)
- Health-related quality of life with enzalutamide versus flutamide in castration-resistant prostate cancer from the AFTERCAB study (2022) (0)
- Testosterone and 5 alpha-reductase (2012) (0)
- Renal dysfunction caused by urological cancer (2017) (0)
- Clinical ef fi cacy and prognostic factors of tumor progression in Japanese patients with advanced renal cell carcinoma treated with sorafenib (2015) (0)
- PROGNOSTIC SIGNIFICANCE OF SNAIL EXPRESSION IN PATIENTS WITH UPPER URINARY TRACT UROTHELIAL CARCINOMA (UUT-UC) (2009) (0)
- Androgen deprivation therapy duration is significantly associated with Testosterone recovery in Japanese patients with prostate cancer (2022) (0)
- PD43-06 IMPACT OF PROSTATIC SHAPE ON THE DIFFICULTY OF ROBOT-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (2020) (0)
- Not all patients who have prostate cancer with seminal vesicle invasion have poor prognosis (2020) (0)
- Editorial Comment. (2019) (0)
- MP82-18 INTRAVESICAL BCG INSTILLATION IS STRONGLY ASSOCIATED WITH A DECREASED RISK OF UPPER TRACT UROTHELIAL CARCINOMA RECURRENCE AS WELL AS INTRAVESICAL RECURRENCE IN ELDERLY MALE PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER (2020) (0)
- Management of patients with advanced prostate cancer in Japan: ‘real-world’ consideration of the results from the Advanced Prostate Cancer Consensus Conference (2021) (0)
- Host immune reactivity as a prognostic factor in interleukin-2 therapy of renal cell carcinoma (1995) (0)
- Evaluating the clinical efficacy of neoadjuvant chemotherapy for node-positive upper tract urothelial carcinoma: A multi-center cohort study (2020) (0)
- MP18-09 ROLE FOR THE ECTONUCLEOTIDASE CD39 (2020) (0)
- OPTIMIZED URINARY PH IS NECESSARY FOR THE IMPROVEMENT OF ADJUVANT MMC INSTILLATION TREATMENT FOR TUMOR RECURRENCE OF NON-MUSCLE INVASIVE BLADDER TUMORS (2009) (0)
- 892 ANGIOTENSIN II TYPE I ANTAGONIST PREVENTS HORMONE-REFRACTORY PROSTATE CANCER BY INHIBITING TUMOR ANGIOGENESIS (2009) (0)
- Whole-tissue biopsy phenotyping of three-dimensional tumours reveals patterns of cancer heterogeneity (2017) (0)
- How to Make Proper Specimens for Surgically Resected Renal Cell Carcinoma (2000) (0)
- Enzalutamide plus androgen deprivation therapy (ADT) versus flutamide plus ADT in men with castration-resistant prostate cancer (CRPC): AFTERCAB. (2021) (0)
- Renal function in advanced renal cell carcinoma patients treated with sorafenib: Subset analyses of post-marketing surveillance in Japan with over 3,200 consecutive cases. (2016) (0)
- Issue Information (2021) (0)
- Issue Information (2021) (0)
- PD31-02 WHAT TIMING IS APPROPRIATE FOR A BIOCHEMICAL EVALUATION AFTER LAPAROSCOPIC ADRENALECTOMY FOR UNILATERAL ALDOSTERONE-PRODUCING ADENOMA? (2020) (0)
- MP16-04 IN SILICO SCREENING FOR IDENTIFICATION OF NOVEL DRUGS FOR OVERCOMING CABAZITAXEL-RESISTANT PROSTATE CANCER (2020) (0)
- [Role of mTOR inhibition in the treatment of metastatic renal cell carcinoma]. (2012) (0)
- COULD ADJUVANT CHEMOTHERAPY HAVE THERAPEUTIC BENEFIT AFTER NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH EQUAL TO OR GREATER THAN PT3 MUSCLE INVASIVE BLADDER CANCER?: MP34‐16 (2017) (0)
- ASSOCIATION OF RADIATION DOSES WITH DEVELOPMENT OF ERECTILE DYSFUNCTION IN PATIENTS WITH LOCALIZED PROSTATE CANCER TREATED WITH PERMANENT PROSTATE BRACHYTHERAPY: MP25‐17 (2017) (0)
- PD1-06 CONTEMPORARY MINIMALLY INVASIVE MANAGEMENT OF ADRENAL DISORDERS: AN INTERNATIONAL MULTI-INSTITUTIONAL SURVEY (2014) (0)
- Publisher Correction: Whole-tissue biopsy phenotyping of three-dimensional tumours reveals patterns of cancer heterogeneity (2018) (0)
- Inhibition of the expression of mitogen-activated protein kinase phosphatase-1 potentiates JNK-related apoptosis in renal cancer cells (2003) (0)
- 2 Natural History of Renal Cell Carcinoma (0)
- Issue Information (2021) (0)
- Erratum to: Subgroup analysis of the AFTER I-O study: a retrospective study on the efficacy and safety of subsequent molecular targeted therapy after immune-oncology therapy in Japanese patients with metastatic renal cell carcinoma (2021) (0)
- THE ANALYSIS OF EXPRESSION AND MOLECULAR MECHANISM FOR VASOHIBIN‐2 IN PROSTATE CANCER: MP64‐18 (2018) (0)
- PD23-11 PROSPECTIVE EVALUATION OF EFFICACY AND SAFETY OF SOLIFENACIN AND MIRABEGRON TREATMENT IN BPH PATIENTS TREATED WITH DUTASTERIDE BUT HAVING OAB SYMPTOMS (2014) (0)
- Identification of FOXO1 as a tumor suppressor modulated by androgen receptor/estrogen receptor-β signals: Implications for bladder cancer promotion and chemoresistance (2020) (0)
- MP49-05 PRETREATMENT ABSOLUTE MONOCYTE COUNT IS A NOVEL BIOMARKER FOR PREDICTING WORSE CLINICAL OUTCOME IN CHEMO-RESISTANT UROTHELIAL CARCINOMA PATIENTS TREATED WITH PEMBROLIZUMAB (2020) (0)
- Issue Information (2021) (0)
- Prediction of extraprostatic extension by MRI tumor contact length: difference between anterior and posterior prostate cancer (2019) (0)
- Early Detection of Neuroendocrine Prostate Cancer as Lineage Plasticity in Recurrent Prostate Cancer After Radiation and Androgen Deprivation Therapy: A Case Report (2020) (0)
- MP11-16 PROSTATE-SPECIFIC ANTIGEN ANALYSES IN PROPEL: ABIRATERONE AND OLAPARIB VERSUS ABIRATERONE AND PLACEBO AS FIRST-LINE THERAPY FOR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (2023) (0)
- PD47-10 MRI TUMOR CONTACT LENGTH AS A PREDICTOR OF EXTRACAPSULAR EXTENSION: OPTIMAL THRESHOLD FOR ANTERIOR AND POSTERIOR PROSTATE CANCER (2018) (0)
- Sub-classification of patients with intermediate-risk metastatic renal cell carcinoma treated with targeted therapy. (2019) (0)
- 698 PROGNOSTIC SIGNIFICANCE OF BCL-XL PROTEIN EXPRESSION ON SURVIVAL IN PATENTS WITH UPPER TRACT UROTHELIAL CARCINOMA TREATED WITH RADICAL NEPHROURETERECTOMY (2013) (0)
- 399 PREDICTIVE VALUE OF POSITIVE URINE CYTOLOGY FOR PROGNOSIS IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA FOLLOWING RADICAL NEPHROURETERECTOMY (2013) (0)
- MP84-20 BIOINFORMATIC ANALYSIS UTILIZING THE ANDROGENIC SUPPRESSIVE EFFECT IDENTIFIED PROMISING CANDIDATE DRUGS FOR REPROGRAMMING DOCETAXEL-RESISTANT CASTRATION-RESISTANT PROSTATE CANCER (2016) (0)
- SIGNIFICANT PROLONGATION OF RENAL ALLOGRAFT SURVIVAL BY APPLYING A NOVEL NF-KAPPA B INHIBITOR, DEHYDROXYMETHYLEPOXYQUINOMICIN, IN A RAT ACUTE REJECTION MODEL: 2729 (2010) (0)
- Could adjuvant chemotherapy have additional therapeutic benefit in muscle invasive bladder cancer patients treated with radical cystectomy and neoadjuvant chemotherapy? (2018) (0)
- 1357 LATE RECURRENCE AND PROGRESSION IN NON-MUSCLE INVASIVE BLADDER CANCERS AFTER 5-YEAR TUMOR-FREE PERIODS: CAN EXISTING RISK STRATIFICATION PROVIDE ACCURATE ESTIMATES OF LATE RECURRENCE AND PROGRESSION? (2010) (0)
- 290 ACTIVATION OF THE ARYL HYDROCARBON RECEPTOR IS ASSOCIATED WITH CIGARETTE SMOKE, POOR PROGNOSIS AND CANCER CELL INVASION IN RENAL CELL CARCINOMA (2010) (0)
- Issue Information (2022) (0)
- 398 CHARACTERISTICS AND OUTCOME IN METASTATIC UPPER TRACT UROTHELIAL CARCINOMA FOLLOWING RADICAL NEPHROURETERECTOMY: THE MULTI-INSTITUTIONAL EXPERIENCE (2013) (0)
- RANKL EXPRESSION IN CLEAR CELL RENAL CELL CARCINOMAS AND ITS ASSOCIATION WITH BONE METASTASIS AND CANCER CELL MIGRATION (2008) (0)
- Torsion of the spermatic cord (2011) (0)
- Recent progress in prognostic and predictive biomarkers for target therapies in metastatic tenat cell carcinoma (2018) (0)
- The Efficacy Of Nasal CPAP On Nocturia In Patients With Obstructive Sleep Apnea (2012) (0)
- Evaluation of efficacy and safety of sorafenib in kidney cancer patients aged 75 years and older: a propensity score-matched analysis (2018) (0)
- PD11-12 COMPARISON OF OUTCOMES BETWEEN ULTRASONOGRAPHY AND CYSTOSCOPY IN THE SURVEILLANCE OF PATIENTS WITH LOW- OR INTERMEDIATE-RISK NON-MUSCLE INVASIVE BLADDER CANCER (2016) (0)
- A comparison of laparoendoscopic single-site surgery versus conventional procedures for laparoscopic donor nephrectomy: a Japanese multi-institutional retrospective study (2019) (0)
- 637 PREOPERATIVE T STAGING AND PREDICTION OF HISTOPATHOLOGIC GRADING OF UROTHELIAL CARCINOMA IN RENAL PELVIS USING DIFFUSION-WEIGHTED MRI (2012) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Mototsugu Oya?
Mototsugu Oya is affiliated with the following schools:
